name,category,terms5'-nucleotidase, ecto (CD73),COG_ONTOLOGY[90000090$Nucleotide transport and metabolism]
5'-nucleotidase, ecto (CD73),INTERPRO[450004322$IPR004843:Metallophosphoesterase, 450005579$IPR006146:5'-Nucleotidase, conserved site, 450005611$IPR006179:5'-Nucleotidase and apyrase, 450007612$IPR008334:5'-Nucleotidase, C-terminal]
5'-nucleotidase, ecto (CD73),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038796$hsa00760:Nicotinate and nicotinamide metabolism]
5'-nucleotidase, ecto (CD73),PIR_SUPERFAMILY[630001043$PIRSF000902:UDP-sugar hydrolase/5'-nucleotidase/apyrase]
5'-nucleotidase, ecto (CD73),SP_PIR_KEYWORDS[790000190$blocked carboxyl end, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000701$homodimer, 790000743$hydrolase, 790000881$lipoprotein, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790000943$metalloprotein, 790001063$nucleotide-binding, 790001149$phosphatidylinositol linkage, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001405$signal, 790001648$zinc]
5'-nucleotidase, ecto (CD73),UP_SEQ_FEATURE[850000555$binding site:Substrate, 850002148$chain:5'-nucleotidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850109701$propeptide:Removed in mature form, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850117814$signal peptide, 850118573$site:Transition state stabilizer]
A kinase (PRKA) anchor protein 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm]
A kinase (PRKA) anchor protein 14,UP_SEQ_FEATURE[850002963$chain:A-kinase anchor protein 14, 850106259$mutagenesis site, 850114538$region of interest:RII-binding, 850118574$splice variant]
ARP3 actin-related protein 3 homolog B (yeast),INTERPRO[450003522$IPR004000:Actin/actin-like, 450014060$IPR015623:Actin-related protein 3]
ARP3 actin-related protein 3 homolog B (yeast),PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
ARP3 actin-related protein 3 homolog B (yeast),SMART[760000240$SM00268:ACTIN]
ARP3 actin-related protein 3 homolog B (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000138$atp-binding, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
ARP3 actin-related protein 3 homolog B (yeast),UP_SEQ_FEATURE[850003634$chain:Actin-related protein 3B, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
ATG4 autophagy related 4 homolog B (S. cerevisiae),INTERPRO[450004547$IPR005078:Peptidase C54]
ATG4 autophagy related 4 homolog B (S. cerevisiae),KEGG_PATHWAY[470038839$hsa04140:Regulation of autophagy]
ATG4 autophagy related 4 homolog B (S. cerevisiae),PIR_SUPERFAMILY[630013771$PIRSF016995:cysteine protease ATG4]
ATG4 autophagy related 4 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000148$autophagy, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001266$protein transport, 790001509$thiol protease, 790001558$transport, 790001593$ubl conjugation pathway]
ATG4 autophagy related 4 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850013262$chain:Cysteine protease ATG4B, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D,INTERPRO[450002395$IPR002699:ATPase, V1/A1 complex, subunit D]
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D,PIR_SUPERFAMILY[630001432$PIRSF001286:H(+)-transporting ATPase chain D]
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790001558$transport]
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D,UP_SEQ_FEATURE[850099801$chain:V-type proton ATPase subunit D, 850117294$sequence conflict]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001599$IPR001806:Ras GTPase, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450004692$IPR005225:Small GTP-binding protein, 450012305$IPR013684:Miro-like]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790000640$GTPase activation, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001558$transport, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1,UP_SEQ_FEATURE[850006011$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850114670$region of interest:Small GTPase-like, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118762$zinc finger region:C4-type]
BCL2/adenovirus E1B 19kDa interacting protein 1,INTERPRO[450005055$IPR005606:Sec20]
BCL2/adenovirus E1B 19kDa interacting protein 1,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
BCL2/adenovirus E1B 19kDa interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
BCL2/adenovirus E1B 19kDa interacting protein 1,UP_SEQ_FEATURE[850100220$chain:Vesicle transport protein SEC20, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
BRI3 binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
BRI3 binding protein,UP_SEQ_FEATURE[850008395$chain:BRI3-binding protein, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
Bardet-Biedl syndrome 1,OMIM_DISEASE[520000507$Bardet-Biedl syndrome 1]
Bardet-Biedl syndrome 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000168$Bardet-Biedl syndrome, 790000264$cell membrane, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001067$obesity, 790001162$phosphoprotein, 790001377$sensory transduction, 790001622$vision]
Bardet-Biedl syndrome 1,UP_SEQ_FEATURE[850007298$chain:Bardet-Biedl syndrome 1 protein, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
CD34 molecule,BBID[10000090$7.IL17_hematopoesis]
CD34 molecule,BIOCARTA[30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes]
CD34 molecule,INTERPRO[450007419$IPR008083:CD34 antigen, 450012437$IPR013836:CD34/Podocalyxin]
CD34 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage]
CD34 molecule,PIR_SUPERFAMILY[630021618$PIRSF028749:sialomucin CD34]
CD34 molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000919$membrane, 790000983$monomer, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
CD34 molecule,UP_SEQ_FEATURE[850023257$chain:Hematopoietic progenitor cell antigen CD34, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CMT1A duplicated region transcript 15,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
CMT1A duplicated region transcript 15,UP_SEQ_FEATURE[850011727$chain:CMT1A duplicated region transcript 15 protein, 850117294$sequence conflict, 850117295$sequence variant]
Cdc2-related kinase, arginine/serine-rich,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
Cdc2-related kinase, arginine/serine-rich,SMART[760000193$SM00220:S_TKc]
Cdc2-related kinase, arginine/serine-rich,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
Cdc2-related kinase, arginine/serine-rich,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010432$chain:Cell division protein kinase 12, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DENN/MADD domain containing 2A,INTERPRO[450001049$IPR001194:DENN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 2A,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 2A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
DENN/MADD domain containing 2A,UP_SEQ_FEATURE[850014828$chain:DENN domain-containing protein 2A, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DNL-type zinc finger,INTERPRO[450007201$IPR007853:Zinc finger, Zim17-type]
DNL-type zinc finger,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
DNL-type zinc finger,UP_SEQ_FEATURE[850016210$chain:DNL-type zinc finger protein, 850117295$sequence variant, 850118804$zinc finger region:DNL-type]
DPH2 homolog (S. cerevisiae),INTERPRO[450002419$IPR002728:Diphthamide synthesis, DPH1/DHP2, 450009098$IPR010014:Diphthamide synthesis, DHP2]
DPH2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
DPH2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850015237$chain:Diphthamide biosynthesis protein 2, 850106258$modified residue, 850117294$sequence conflict]
DnaJ (Hsp40) homolog, subfamily C, member 8,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 8,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 8,SP_PIR_KEYWORDS[790000012$acetylation, 790000288$Chaperone, 790000356$complete proteome, 790001162$phosphoprotein]
DnaJ (Hsp40) homolog, subfamily C, member 8,UP_SEQ_FEATURE[850016187$chain:DnaJ homolog subfamily C member 8, 850104487$domain:J, 850106258$modified residue, 850117294$sequence conflict]
ELKS/RAB6-interacting/CAST family member 1,INTERPRO[450017288$IPR019018:Rab11-binding domain , FIP domain, C-terminal, 450017561$IPR019323:CAZ complex, RIM-binding protein]
ELKS/RAB6-interacting/CAST family member 1,PIR_SUPERFAMILY[630029835$PIRSF038226:cast]
ELKS/RAB6-interacting/CAST family member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
ELKS/RAB6-interacting/CAST family member 1,UP_SEQ_FEATURE[850017068$chain:ELKS/RAB6-interacting/CAST family member 1, 850105153$domain:RBD-FIP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117876$site:Breakpoint for translocation to form ERC1-RET oncogene, 850118574$splice variant]
Fas apoptotic inhibitory molecule 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fas apoptotic inhibitory molecule 3,SMART[760000357$SM00409:IG]
Fas apoptotic inhibitory molecule 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 3,UP_SEQ_FEATURE[850018982$chain:Fas apoptotic inhibitory molecule 3, 850102404$compositionally biased region:Arg-rich, 850102883$disulfide bond, 850104199$domain:Ig-like, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G antigen 2A; G antigen 2B; G antigen 12I; G antigen 12F; G antigen 2E; G antigen 12G; G antigen 12D; G antigen 1; G antigen 2C; G antigen 12E; G antigen 2D; G antigen 12B; G antigen 3; G antigen 4; G antigen 12C; G antigen 5; G antigen 6; G antigen 7; G antigen 8,INTERPRO[450007883$IPR008625:GAGE]
G antigen 2A; G antigen 2B; G antigen 12I; G antigen 12F; G antigen 2E; G antigen 12G; G antigen 12D; G antigen 1; G antigen 2C; G antigen 12E; G antigen 2D; G antigen 12B; G antigen 3; G antigen 4; G antigen 12C; G antigen 5; G antigen 6; G antigen 7; G antigen 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
G antigen 2A; G antigen 2B; G antigen 12I; G antigen 12F; G antigen 2E; G antigen 12G; G antigen 12D; G antigen 1; G antigen 2C; G antigen 12E; G antigen 2D; G antigen 12B; G antigen 3; G antigen 4; G antigen 12C; G antigen 5; G antigen 6; G antigen 7; G antigen 8,UP_SEQ_FEATURE[850020211$chain:G antigen 1, 850020213$chain:G antigen 12C/D/E, 850020214$chain:G antigen 12F/G/I, 850020218$chain:G antigen 2A/2B, 850020219$chain:G antigen 3, 850020220$chain:G antigen 4, 850020221$chain:G antigen 5, 850020222$chain:G antigen 6, 850020223$chain:G antigen 7, 850020224$chain:G antigen 8, 850106258$modified residue, 850117294$sequence conflict]
G protein-coupled receptor 56,INTERPRO[450000174$IPR000203:GPS, 450000724$IPR000832:GPCR, family 2, secretin-like, 450003435$IPR003910:GPCR, family 2, orphan receptor, GPR56, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site]
G protein-coupled receptor 56,OMIM_DISEASE[520004047$Polymicrogyria, bilateral frontoparietal]
G protein-coupled receptor 56,PIR_SUPERFAMILY[630030175$PIRSF038673:G protein-coupled receptor 56, 630031208$PIRSF800007:secretin receptor-like G protein-coupled receptors]
G protein-coupled receptor 56,SMART[760000273$SM00303:GPS]
G protein-coupled receptor 56,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 56,UP_SEQ_FEATURE[850020290$chain:G-protein coupled receptor 56, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
GDNF family receptor alpha 3,INTERPRO[450003005$IPR003438:Glial cell line-derived neurotrophic factor receptor, 450003073$IPR003505:Glial cell line-derived neurotrophic factor receptor, alpha 3, 450014416$IPR016017:GDNF/GAS1]
GDNF family receptor alpha 3,PIR_SUPERFAMILY[630012048$PIRSF015163:Mus musculus GPI-linked receptor]
GDNF family receptor alpha 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal]
GDNF family receptor alpha 3,UP_SEQ_FEATURE[850020729$chain:GDNF family receptor alpha-3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105856$lipid moiety-binding region:GPI-anchor amidated asparagine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
GTPase, IMAP family member 8,INTERPRO[450006113$IPR006703:AIG1]
GTPase, IMAP family member 8,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000639$gtp-binding, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism]
GTPase, IMAP family member 8,UP_SEQ_FEATURE[850022640$chain:GTPase IMAP family member 8, 850102576$compositionally biased region:Poly-Leu, 850102585$compositionally biased region:Poly-Val, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant]
H1 histone family, member O, oocyte-specific,INTERPRO[450005266$IPR005818:Histone H1/H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
H1 histone family, member O, oocyte-specific,SMART[760000466$SM00526:H15]
H1 histone family, member O, oocyte-specific,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000315$chromosomal protein, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000915$meiosis, 790001065$nucleus, 790001212$polymorphism]
H1 histone family, member O, oocyte-specific,UP_SEQ_FEATURE[850023964$chain:Histone H1oo, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
H2A histone family, member B1,INTERPRO[450001877$IPR002119:Histone H2A, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H2A histone family, member B1,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H2A histone family, member B1,SMART[760000361$SM00414:H2A]
H2A histone family, member B1,SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001058$nucleosome core, 790001065$nucleus]
H2A histone family, member B1,UP_SEQ_FEATURE[850023990$chain:Histone H2A-Bbd type 1, 850111470$region of interest:Docking domain]
InaD-like (Drosophila),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450003682$IPR004172:L27, 450013579$IPR015132:L27-2]
InaD-like (Drosophila),KEGG_PATHWAY[470038857$hsa04530:Tight junction]
InaD-like (Drosophila),SMART[760000200$SM00228:PDZ, 760000506$SM00569:L27]
InaD-like (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001528$Tight junction]
InaD-like (Drosophila),UP_SEQ_FEATURE[850025701$chain:InaD-like protein, 850104597$domain:L27, 850104919$domain:PDZ 1, 850104920$domain:PDZ 10, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850104929$domain:PDZ 7, 850104930$domain:PDZ 8, 850104931$domain:PDZ 9, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
KIAA1305,INTERPRO[450001406$IPR001584:Integrase, catalytic core]
KIAA1305,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
KIAA1305,UP_SEQ_FEATURE[850026221$chain:Integrase catalytic domain-containing protein KIAA1305, 850104419$domain:Integrase catalytic, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
KIAA1602,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
KIAA1602,UP_SEQ_FEATURE[850033780$chain:Nck-associated protein 5-like, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
KIAA1614,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
KIAA1614,UP_SEQ_FEATURE[850075556$chain:Uncharacterized protein KIAA1614, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
LIM domain binding 1,BIOCARTA[30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2]
LIM domain binding 1,INTERPRO[450002388$IPR002691:LIM binding protein]
LIM domain binding 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
LIM domain binding 1,UP_SEQ_FEATURE[850028659$chain:LIM domain-binding protein 1, 850106258$modified residue, 850106259$mutagenesis site, 850113276$region of interest:LIM-binding domain (LID), 850117295$sequence variant, 850118574$splice variant]
LPS-responsive vesicle trafficking, beach and anchor containing,INTERPRO[450000352$IPR000409:Beige/BEACH, 450001490$IPR001680:WD40 repeat, 450009562$IPR010508:Protein of unknown function DUF1088, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup]
LPS-responsive vesicle trafficking, beach and anchor containing,SMART[760000289$SM00320:WD40]
LPS-responsive vesicle trafficking, beach and anchor containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000897$lysosome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001638$wd repeat]
LPS-responsive vesicle trafficking, beach and anchor containing,UP_SEQ_FEATURE[850028823$chain:Lipopolysaccharide-responsive and beige- like anchor protein, 850102566$compositionally biased region:Poly-Arg, 850103097$domain:BEACH, 850105852$helix, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118623$transmembrane region, 850118624$turn]
MANSC domain containing 1,INTERPRO[450010047$IPR011106:Seven cysteines, N-terminal, 450012574$IPR013980:Seven cysteines]
MANSC domain containing 1,SMART[760000671$SM00765:MANEC]
MANSC domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
MANSC domain containing 1,UP_SEQ_FEATURE[850030481$chain:MANSC domain-containing protein 1, 850102605$compositionally biased region:Thr-rich, 850104754$domain:MANSC, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MIF4G domain containing,INTERPRO[450003415$IPR003890:MIF4G-like, type 3, 450014420$IPR016021:MIF4-like, type 1/2/3]
MIF4G domain containing,SMART[760000483$SM00543:MIF4G]
MIF4G domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001551$translation regulation]
MIF4G domain containing,UP_SEQ_FEATURE[850031734$chain:MIF4G domain-containing protein, 850104778$domain:MIF4G, 850118574$splice variant]
MYST histone acetyltransferase (monocytic leukemia) 4,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002410$IPR002717:MOZ/SAS-like protein, 450005266$IPR005818:Histone H1/H5, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014522$IPR016181:Acyl-CoA N-acyltransferase, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
MYST histone acetyltransferase (monocytic leukemia) 4,SMART[760000221$SM00249:PHD, 760000466$SM00526:H15]
MYST histone acetyltransferase (monocytic leukemia) 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000025$Acyltransferase, 790000053$alternative splicing, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
MYST histone acetyltransferase (monocytic leukemia) 4,UP_SEQ_FEATURE[850023870$chain:Histone acetyltransferase MYST4, 850102562$compositionally biased region:Met-rich, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850111190$region of interest:Catalytic, 850112133$region of interest:Interaction with BRPF1, 850112798$region of interest:Interaction with RUNX1 and RUNX2, 850113734$region of interest:Negatively regulates HAT activity, 850117294$sequence conflict, 850117295$sequence variant, 850117914$site:Breakpoint for translocation to form MYST4-CREBBP, 850118574$splice variant, 850118743$zinc finger region:C2HC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),INTERPRO[450000154$IPR000182:GCN5-related N-acetyltransferase, 450014522$IPR016181:Acyl-CoA N-acyltransferase]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),PIR_SUPERFAMILY[630021012$PIRSF027824:PIRSF027824]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000428$developmental protein, 790000586$gastrulation, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),UP_SEQ_FEATURE[850042887$chain:Probable N-acetyltransferase 8, 850042888$chain:Probable N-acetyltransferase 8B, 850104817$domain:N-acetyltransferase, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,INTERPRO[450008527$IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,PIR_SUPERFAMILY[630014491$PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2, 630014492$PIRSF017834:NADH-UbQ_OxRdtase_b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001555$transmembrane, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,UP_SEQ_FEATURE[850033542$chain:NADH dehydrogenase [ubiquinone] 1 subunit C2, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
NUAK family, SNF1-like kinase, 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
NUAK family, SNF1-like kinase, 1,SMART[760000193$SM00220:S_TKc]
NUAK family, SNF1-like kinase, 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
NUAK family, SNF1-like kinase, 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850034801$chain:NUAK family SNF1-like kinase 1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Norrie disease (pseudoglioma),INTERPRO[450002690$IPR003064:Norrie disease protein, 450005633$IPR006207:Cystine knot, C-terminal]
Norrie disease (pseudoglioma),OMIM_DISEASE[520001837$Exudative vitreoretinopathy, X-linked, 520003684$Norrie disease]
Norrie disease (pseudoglioma),PIR_SUPERFAMILY[630014843$PIRSF018206:norrin]
Norrie disease (pseudoglioma),SMART[760000033$SM00041:CT]
Norrie disease (pseudoglioma),SP_PIR_KEYWORDS[790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000447$disulfide bond, 790001212$polymorphism, 790001363$Secreted, 790001377$sensory transduction, 790001405$signal, 790001622$vision, 790001642$wnt signaling pathway]
Norrie disease (pseudoglioma),UP_SEQ_FEATURE[850034724$chain:Norrin, 850102883$disulfide bond, 850103430$domain:CTCK, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide]
PC4 and SFRS1 interacting protein 1,INTERPRO[450000267$IPR000313:PWWP]
PC4 and SFRS1 interacting protein 1,SMART[760000264$SM00293:PWWP]
PC4 and SFRS1 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000533$eye lens, 790000616$glycoprotein, 790000632$growth factor, 790000635$growth regulation, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
PC4 and SFRS1 interacting protein 1,UP_SEQ_FEATURE[850036959$chain:PC4 and SFRS1-interacting protein, 850105126$domain:PWWP, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
PDZ and LIM domain 2 (mystique),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001575$IPR001781:Zinc finger, LIM-type]
PDZ and LIM domain 2 (mystique),PIR_SUPERFAMILY[630014741$PIRSF018094:PDZ and LIM domain protein]
PDZ and LIM domain 2 (mystique),SMART[760000114$SM00132:LIM, 760000200$SM00228:PDZ]
PDZ and LIM domain 2 (mystique),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000864$LIM domain, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001648$zinc]
PDZ and LIM domain 2 (mystique),UP_SEQ_FEATURE[850036978$chain:PDZ and LIM domain protein 2, 850102597$compositionally biased region:Ser-rich, 850104716$domain:LIM zinc-binding, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
PDZ domain containing 7,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
PDZ domain containing 7,SMART[760000200$SM00228:PDZ]
PDZ domain containing 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
PDZ domain containing 7,UP_SEQ_FEATURE[850036987$chain:PDZ domain-containing protein 7, 850102597$compositionally biased region:Ser-rich, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
RAB18, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450001841$IPR002078:RNA polymerase sigma factor 54, interaction, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014037$IPR015598:Rab18]
RAB18, member RAS oncogene family,PIR_SUPERFAMILY[630001856$PIRSF001710:Ras-related protein Rab, 630030796$PIRSF500600:Ras-related protein Rab18]
RAB18, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB18, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB18, member RAS oncogene family,UP_SEQ_FEATURE[850056761$chain:Ras-related protein Rab-18, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAD52 homolog (S. cerevisiae),INTERPRO[450004077$IPR004585:Recombination protein Rad52, 450006601$IPR007232:Rad52/22 double-strand break repair protein]
RAD52 homolog (S. cerevisiae),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
RAD52 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
RAD52 homolog (S. cerevisiae),UP_SEQ_FEATURE[850015761$chain:DNA repair protein RAD52 homolog, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,INTERPRO[450000132$IPR000156:Ran Binding Protein 1, 450000205$IPR000237:GRIP, 450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450010818$IPR011993:Pleckstrin homology-type, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,SMART[760000020$SM00028:TPR, 760000141$SM00160:RanBD, 760000661$SM00755:Grip]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,UP_SEQ_FEATURE[850056643$chain:RANBP2-like and GRIP domain-containing protein 4, 850056644$chain:RANBP2-like and GRIP domain-containing protein 5, 850056645$chain:RANBP2-like and GRIP domain-containing protein 6, 850056646$chain:RANBP2-like and GRIP domain-containing protein 7, 850102581$compositionally biased region:Poly-Ser, 850104082$domain:GRIP, 850105139$domain:RanBD1 1, 850105140$domain:RanBD1 2, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850118574$splice variant]
RAR-related orphan receptor C,INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450002705$IPR003079:Nuclear receptor ROR, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
RAR-related orphan receptor C,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
RAR-related orphan receptor C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
RAR-related orphan receptor C,UP_SEQ_FEATURE[850035040$chain:Nuclear receptor ROR-gamma, 850102570$compositionally biased region:Poly-Gln, 850102946$DNA-binding region:Nuclear receptor, 850111880$region of interest:Hinge, 850113269$region of interest:Ligand-binding, 850113461$region of interest:Modulating, 850118574$splice variant, 850118866$zinc finger region:NR C4-type]
RAS p21 protein activator 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001388$IPR001562:Zinc finger, Btk motif, 450001635$IPR001849:Pleckstrin homology, 450001714$IPR001936:Ras GTPase-activating protein, 450010818$IPR011993:Pleckstrin homology-type, 450016334$IPR018029:C2 membrane targeting protein]
RAS p21 protein activator 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
RAS p21 protein activator 2,SMART[760000094$SM00107:BTK, 760000205$SM00233:PH, 760000211$SM00239:C2, 760000292$SM00323:RasGAP]
RAS p21 protein activator 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
RAS p21 protein activator 2,UP_SEQ_FEATURE[850056684$chain:Ras GTPase-activating protein 2, 850102378$compositionally biased region:Ala-rich, 850103200$domain:C2 1, 850103201$domain:C2 2, 850104979$domain:PH, 850105148$domain:Ras-GAP, 850106258$modified residue, 850117294$sequence conflict, 850118652$zinc finger region:Btk-type]
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450015671$IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly]
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)),PIR_SUPERFAMILY[630029563$PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type, 630029564$PIRSF037992:hnRNP-C_Raly]
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)),SMART[760000328$SM00360:RRM]
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001433$Spliceosome]
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)),UP_SEQ_FEATURE[850058532$chain:RNA-binding protein Raly, 850102573$compositionally biased region:Poly-Gly, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850111596$region of interest:Epitope (recognized by BKRF1 antibodies), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
RNA terminal phosphate cyclase domain 1,INTERPRO[450000197$IPR000228:RNA 3'-terminal phosphate cyclase- like, 450012405$IPR013796:RNA 3'-terminal phosphate cyclase, insert region, 450016092$IPR017770:RNA 3'-terminal phosphate cyclase, subgroup]
RNA terminal phosphate cyclase domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790001063$nucleotide-binding, 790001065$nucleus]
RNA terminal phosphate cyclase domain 1,UP_SEQ_FEATURE[850058330$chain:RNA 3'-terminal phosphate cyclase, 850117294$sequence conflict, 850118574$splice variant]
RUN and SH3 domain containing 2,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN, 450010373$IPR011511:Variant SH3]
RUN and SH3 domain containing 2,SMART[760000295$SM00326:SH3, 760000527$SM00593:RUN]
RUN and SH3 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
RUN and SH3 domain containing 2,UP_SEQ_FEATURE[850026732$chain:Iporin, 850102572$compositionally biased region:Poly-Glu, 850105223$domain:RUN, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
RUN domain containing 1,INTERPRO[450003532$IPR004012:RUN]
RUN domain containing 1,SMART[760000527$SM00593:RUN]
RUN domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
RUN domain containing 1,UP_SEQ_FEATURE[850058690$chain:RUN domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850105223$domain:RUN, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
Rap guanine nucleotide exchange factor (GEF) 6,INTERPRO[450000135$IPR000159:Ras-association, 450000508$IPR000595:Cyclic nucleotide-binding, 450000558$IPR000651:Guanine nucleotide exchange factor for Ras-like GTPases, N-terminal, 450001316$IPR001478:PDZ/DHR/GLGF, 450001677$IPR001895:Guanine-nucleotide dissociation stimulator CDC25, 450008163$IPR008937:Ras guanine nucleotide exchange factor, 450013163$IPR014710:RmlC-like jelly roll fold]
Rap guanine nucleotide exchange factor (GEF) 6,SMART[760000088$SM00100:cNMP, 760000129$SM00147:RasGEF, 760000200$SM00228:PDZ, 760000201$SM00229:RasGEFN, 760000284$SM00314:RA]
Rap guanine nucleotide exchange factor (GEF) 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
Rap guanine nucleotide exchange factor (GEF) 6,UP_SEQ_FEATURE[850056656$chain:Rap guanine nucleotide exchange factor 6, 850102597$compositionally biased region:Ser-rich, 850104821$domain:N-terminal Ras-GEF, 850104918$domain:PDZ, 850105145$domain:Ras-associating, 850105149$domain:Ras-GEF, 850105852$helix, 850106258$modified residue, 850106279$nucleotide phosphate-binding region:cNMP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
Rho GTPase activating protein 11B; Rho GTPase activating protein 11A,INTERPRO[450000169$IPR000198:RhoGAP]
Rho GTPase activating protein 11B; Rho GTPase activating protein 11A,SMART[760000293$SM00324:RhoGAP]
Rho GTPase activating protein 11B; Rho GTPase activating protein 11A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism]
Rho GTPase activating protein 11B; Rho GTPase activating protein 11A,UP_SEQ_FEATURE[850057526$chain:Rho GTPase-activating protein 11A, 850057527$chain:Rho GTPase-activating protein 11B, 850105183$domain:Rho-GAP, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
Rho GTPase activating protein 12,INTERPRO[450000169$IPR000198:RhoGAP, 450001055$IPR001202:WW/Rsp5/WWP, 450001294$IPR001452:Src homology-3 domain, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450014201$IPR015767:Rho GTPase activating]
Rho GTPase activating protein 12,PIR_SUPERFAMILY[630029862$PIRSF038267:Rho GTPase-activating protein, ARHGAP12 type]
Rho GTPase activating protein 12,SMART[760000205$SM00233:PH, 760000293$SM00324:RhoGAP, 760000295$SM00326:SH3, 760000401$SM00456:WW]
Rho GTPase activating protein 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain]
Rho GTPase activating protein 12,UP_SEQ_FEATURE[850057528$chain:Rho GTPase-activating protein 12, 850104979$domain:PH, 850105183$domain:Rho-GAP, 850105350$domain:SH3, 850105732$domain:WW 1, 850105733$domain:WW 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Rho GTPase-activating protein,INTERPRO[450000169$IPR000198:RhoGAP, 450001294$IPR001452:Src homology-3 domain]
Rho GTPase-activating protein,SMART[760000293$SM00324:RhoGAP, 760000295$SM00326:SH3]
Rho GTPase-activating protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000501$endosome, 790000624$golgi apparatus, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001398$sh3 domain, 790001475$synapse]
Rho GTPase-activating protein,UP_SEQ_FEATURE[850057611$chain:Rho/Cdc42/Rac GTPase-activating protein RICS, 850102580$compositionally biased region:Poly-Pro, 850105130$domain:PX; atypical, 850105183$domain:Rho-GAP, 850105350$domain:SH3, 850106258$modified residue, 850106259$mutagenesis site, 850112345$region of interest:Interaction with FYN, 850112349$region of interest:Interaction with GAB2, 850118574$splice variant]
S100 calcium binding protein A7A,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A7A,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A7A,SP_PIR_KEYWORDS[790000012$acetylation, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
S100 calcium binding protein A7A,UP_SEQ_FEATURE[850000624$calcium-binding region:2; high affinity, 850047567$chain:Protein S100-A7A, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117295$sequence variant]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,INTERPRO[450002837$IPR003228:Transcription initiation factor TFIID, 450008207$IPR009072:Histone-fold]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,UP_SEQ_FEATURE[850065451$chain:Transcription initiation factor TFIID subunit 12, 850105852$helix, 850106258$modified residue, 850118574$splice variant]
TBC1 domain family, member 12,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 12,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 12,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein]
TBC1 domain family, member 12,UP_SEQ_FEATURE[850063653$chain:TBC1 domain family member 12, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850117294$sequence conflict]
TatD DNase domain containing 1,INTERPRO[450000991$IPR001130:Deoxyribonuclease, TatD-related, 450010991$IPR012278:Deoxyribonuclease, TatD Mg-dependent, 450014394$IPR015992:Deoxyribonuclease, TatD, 450016513$IPR018228:Deoxyribonuclease, TatD-related, conserved site]
TatD DNase domain containing 1,PIR_SUPERFAMILY[630005834$PIRSF005902:DNase_TatD, 630005835$PIRSF005902:Mg-dependent DNase, TatD type]
TatD DNase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus]
TatD DNase domain containing 1,UP_SEQ_FEATURE[850050480$chain:Putative deoxyribonuclease TATDN1, 850117294$sequence conflict, 850118574$splice variant]
UDP glucuronosyltransferase 2 family, polypeptide B15,INTERPRO[450001963$IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase]
UDP glucuronosyltransferase 2 family, polypeptide B15,KEGG_PATHWAY[470038728$hsa00040:Pentose and glucuronate interconversions, 470038731$hsa00053:Ascorbate and aldarate metabolism, 470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism, 470038765$hsa00500:Starch and sucrose metabolism, 470038801$hsa00830:Retinol metabolism, 470038802$hsa00860:Porphyrin and chlorophyll metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
UDP glucuronosyltransferase 2 family, polypeptide B15,PIR_SUPERFAMILY[630005607$PIRSF005678:glucuronosyltransferase]
UDP glucuronosyltransferase 2 family, polypeptide B15,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000691$hexosyltransferase, 790000919$membrane, 790000959$microsome, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
UDP glucuronosyltransferase 2 family, polypeptide B15,UP_SEQ_FEATURE[850068247$chain:UDP-glucuronosyltransferase 2B15, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,INTERPRO[450002359$IPR002659:Glycosyl transferase, family 31]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4,UP_SEQ_FEATURE[850068198$chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
WAP four-disulfide core domain 6; serine peptidase inhibitor-like, with Kunitz and WAP domains 1 (eppin),INTERPRO[450001971$IPR002223:Proteinase inhibitor I2, Kunitz metazoa, 450007512$IPR008197:Whey acidic protein, 4-disulphide core, 450016370$IPR018069:Whey acidic protein, 4-disulphide core, conserved site]
WAP four-disulfide core domain 6; serine peptidase inhibitor-like, with Kunitz and WAP domains 1 (eppin),SMART[760000113$SM00131:KU, 760000190$SM00217:WAP]
WAP four-disulfide core domain 6; serine peptidase inhibitor-like, with Kunitz and WAP domains 1 (eppin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790001212$polymorphism, 790001253$protease inhibitor, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal]
WAP four-disulfide core domain 6; serine peptidase inhibitor-like, with Kunitz and WAP domains 1 (eppin),UP_SEQ_FEATURE[850017718$chain:Eppin, 850100664$chain:WAP four-disulfide core domain protein 6, 850102883$disulfide bond, 850103140$domain:BPTI/Kunitz inhibitor, 850105688$domain:WAP, 850105695$domain:WAP; atypical, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
WW domain containing E3 ubiquitin protein ligase 1,COG_ONTOLOGY[90000102$RNA processing and modification]
WW domain containing E3 ubiquitin protein ligase 1,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000485$IPR000569:HECT, 450001055$IPR001202:WW/Rsp5/WWP, 450016334$IPR018029:C2 membrane targeting protein]
WW domain containing E3 ubiquitin protein ligase 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038841$hsa04144:Endocytosis]
WW domain containing E3 ubiquitin protein ligase 1,PIR_SUPERFAMILY[630001740$PIRSF001569:E3 ubiquitin-protein ligase, Nedd4/Rsp5p types]
WW domain containing E3 ubiquitin protein ligase 1,SMART[760000104$SM00119:HECTc, 760000211$SM00239:C2, 760000401$SM00456:WW]
WW domain containing E3 ubiquitin protein ligase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000733$host-virus interaction, 790000859$ligase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
WW domain containing E3 ubiquitin protein ligase 1,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850033801$chain:NEDD4-like E3 ubiquitin-protein ligase WWP1, 850103199$domain:C2, 850104105$domain:HECT, 850105732$domain:WW 1, 850105733$domain:WW 2, 850105734$domain:WW 3, 850105735$domain:WW 4, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118545$site:Required for ubiquitin-thioester formation, 850118574$splice variant, 850118575$strand, 850118624$turn]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),BBID[10000104$82.TCR_and_Cap_or_SMAC]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding, 450000597$IPR000697:EVH1, 450002748$IPR003124:Actin-binding WH2, 450010818$IPR011993:Pleckstrin homology-type]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038856$hsa04520:Adherens junction, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038898$hsa05130:Pathogenic Escherichia coli infection]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),OMIM_DISEASE[520003629$Neutropenia, severe congenital, X-linked, 520004827$Thrombocytopenia, X-linked, 520004828$Thrombocytopenia, X-linked, intermittent, 520005103$Wiskott-Aldrich syndrome]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),PIR_SUPERFAMILY[630029126$PIRSF037537:Wasp protein, metazoan type]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),SMART[760000218$SM00246:WH2, 760000256$SM00285:PBD, 760000406$SM00461:WH1]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000446$disease mutation, 790000765$immunodeficiency, 790001162$phosphoprotein, 790001304$repeat]
Wiskott-Aldrich syndrome (eczema-thrombocytopenia),UP_SEQ_FEATURE[850100900$chain:Wiskott-Aldrich syndrome protein, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102580$compositionally biased region:Poly-Pro, 850103411$domain:CRIB, 850105697$domain:WH1, 850105698$domain:WH2, 850105852$helix, 850106258$modified residue, 850116105$repeat:GRSGPLPPXP motif 1, 850116106$repeat:GRSGPLPPXP motif 2, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,INTERPRO[450000500$IPR000587:Creatinase, 450000865$IPR000994:Peptidase M24, structural domain, 450000992$IPR001131:Peptidase M24B, X-Pro dipeptidase/aminopeptidase P, conserved site]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,PIR_SUPERFAMILY[630006687$PIRSF006732:pig X-Pro aminopeptidase]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000069$Aminopeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000906$manganese, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,UP_SEQ_FEATURE[850100987$chain:Xaa-Pro aminopeptidase 1, 850105852$helix, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
abhydrolase domain containing 8,INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1]
abhydrolase domain containing 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase]
abhydrolase domain containing 8,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003163$chain:Abhydrolase domain-containing protein 8, 850117294$sequence conflict]
acyl-CoA thioesterase 13,INTERPRO[450003278$IPR003736:Phenylacetic acid degradation-related protein, 450006093$IPR006683:Thioesterase superfamily]
acyl-CoA thioesterase 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000969$mitochondrion]
acyl-CoA thioesterase 13,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850003769$chain:Acyl-coenzyme A thioesterase 13, 850105852$helix, 850106259$mutagenesis site, 850118575$strand, 850118624$turn]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450002186$IPR002466:Adenosine deaminase/editase, 450013172$IPR014720:Double-stranded RNA-binding-like]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),OMIM_DISEASE[520001932$Framingham Heart Study genome-wide association: results for pulmonary function measures]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),PIR_SUPERFAMILY[630001393$PIRSF001248:double-stranded RNA-specific adenosine deaminase]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),SMART[760000326$SM00358:DSRM, 760000492$SM00552:ADEAMc]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000988$mrna processing, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001648$zinc]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000433$binding site:Inositol hexakisphosphate, 850016332$chain:Double-stranded RNA-specific editase 1, 850102990$domain:A to I editase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
adenosine monophosphate deaminase (isoform E),INTERPRO[450001209$IPR001365:Adenosine/AMP deaminase, 450005754$IPR006329:AMP deaminase, 450006065$IPR006650:Adenosine/AMP deaminase active site, 450014621$IPR016297:AMP deaminase, metazoa]
adenosine monophosphate deaminase (isoform E),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenosine monophosphate deaminase (isoform E),OMIM_DISEASE[520000266$AMP deaminase deficiency, erythrocytic]
adenosine monophosphate deaminase (isoform E),PIR_SUPERFAMILY[630001397$PIRSF001251:AMP_deaminase_met]
adenosine monophosphate deaminase (isoform E),SP_PIR_KEYWORDS[790000051$alternative initiators, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000512$erythrocyte, 790000743$hydrolase, 790001062$nucleotide metabolism, 790001162$phosphoprotein, 790001212$polymorphism]
adenosine monophosphate deaminase (isoform E),UP_SEQ_FEATURE[850005143$chain:AMP deaminase 3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
adenylate kinase 2,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 2,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenylate kinase 2,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001097$P-loop, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase]
adenylate kinase 2,UP_SEQ_FEATURE[850000229$binding site:AMP, 850003913$chain:Adenylate kinase 2, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
adenylate kinase 3,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 3,KEGG_PATHWAY[470038744$hsa00240:Pyrimidine metabolism]
adenylate kinase 3,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000639$gtp-binding, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001547$transferase]
adenylate kinase 3,UP_SEQ_FEATURE[850000229$binding site:AMP, 850022628$chain:GTP:AMP phosphotransferase mitochondrial, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
adhesion molecule with Ig-like domain 2,COG_ONTOLOGY[90000070$Function unknown]
adhesion molecule with Ig-like domain 2,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
adhesion molecule with Ig-like domain 2,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000357$SM00409:IG]
adhesion molecule with Ig-like domain 2,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001065$nucleus, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
adhesion molecule with Ig-like domain 2,UP_SEQ_FEATURE[850005153$chain:Amphoterin-induced protein 2, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
aldo-keto reductase family 1, member B1 (aldose reductase),INTERPRO[450001240$IPR001395:Aldo/keto reductase, 450016460$IPR018170:Aldo/keto reductase, conserved site]
aldo-keto reductase family 1, member B1 (aldose reductase),KEGG_PATHWAY[470038728$hsa00040:Pentose and glucuronate interconversions, 470038729$hsa00051:Fructose and mannose metabolism, 470038730$hsa00052:Galactose metabolism, 470038775$hsa00561:Glycerolipid metabolism, 470038787$hsa00620:Pyruvate metabolism]
aldo-keto reductase family 1, member B1 (aldose reductase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
aldo-keto reductase family 1, member B1 (aldose reductase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000555$binding site:Substrate, 850004374$chain:Aldose reductase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand, 850118624$turn]
alkB, alkylation repair homolog 3 (E. coli),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000437$dioxygenase, 790000452$DNA damage, 790000459$dna repair, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001212$polymorphism, 790001626$vitamin c]
alkB, alkylation repair homolog 3 (E. coli),UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850000555$binding site:Substrate, 850004814$chain:Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3, 850103759$domain:Fe2OG dioxygenase, 850105852$helix, 850106100$metal ion-binding site:Iron; catalytic, 850106259$mutagenesis site, 850110916$region of interest:Alpha-ketoglutarate binding, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118568$site:Susceptible to oxidation, 850118574$splice variant, 850118575$strand]
alkaline phosphatase, intestinal,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF]
alkaline phosphatase, intestinal,INTERPRO[450001728$IPR001952:Alkaline phosphatase, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha, 450016583$IPR018299:Alkaline phosphatase, active site]
alkaline phosphatase, intestinal,KEGG_PATHWAY[470038800$hsa00790:Folate biosynthesis]
alkaline phosphatase, intestinal,PIR_SUPERFAMILY[630001030$PIRSF000891:alkaline phosphatase]
alkaline phosphatase, intestinal,SMART[760000086$SM00098:alkPPc]
alkaline phosphatase, intestinal,SP_PIR_KEYWORDS[790000190$blocked carboxyl end, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000701$homodimer, 790000743$hydrolase, 790000881$lipoprotein, 790000899$magnesium, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790000943$metalloprotein, 790001149$phosphatidylinositol linkage, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane, 790001648$zinc]
alkaline phosphatase, intestinal,UP_SEQ_FEATURE[850000109$active site:Phosphoserine intermediate, 850026642$chain:Intestinal-type alkaline phosphatase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105858$lipid moiety-binding region:GPI-anchor amidated aspartate, 850106107$metal ion-binding site:Magnesium, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
amidohydrolase domain containing 2,INTERPRO[450003305$IPR003764:N-acetylglucosamine-6-phosphate deacetylase, 450006091$IPR006680:Amidohydrolase 1, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site]
amidohydrolase domain containing 2,KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
amidohydrolase domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000743$hydrolase, 790001212$polymorphism]
amidohydrolase domain containing 2,UP_SEQ_FEATURE[850052807$chain:Putative N-acetylglucosamine-6-phosphate deacetylase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 26,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
ankyrin repeat domain 26,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 26,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 26,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 26,UP_SEQ_FEATURE[850005381$chain:Ankyrin repeat domain-containing protein 26, 850102568$compositionally biased region:Poly-Asp, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 55,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 55,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 55,UP_SEQ_FEATURE[850005409$chain:Ankyrin repeat domain-containing protein 55, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117295$sequence variant, 850118574$splice variant]
annexin A11,INTERPRO[450001304$IPR001464:Annexin, 450007488$IPR008157:Annexin, type XI, N-terminal, 450013917$IPR015475:Annexin XI, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A11,PIR_SUPERFAMILY[630002478$PIRSF002360:annexin VII]
annexin A11,SMART[760000303$SM00335:ANX]
annexin A11,SP_PIR_KEYWORDS[790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000473$duplication, 790000497$endonexin fold, 790000616$glycoprotein, 790001065$nucleus, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
annexin A11,UP_SEQ_FEATURE[850005451$chain:Annexin A11, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850117295$sequence variant]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F,INTERPRO[450007252$IPR007904:APOBEC-like, C-terminal, 450011795$IPR013158:APOBEC-like, N-terminal, 450014525$IPR016192:APOBEC/CMP deaminase, zinc-binding]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000104$Antiviral defense, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000743$hydrolase, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001592$ubl conjugation, 790001648$zinc]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850015534$chain:DNA dC->dU-editing enzyme APOBEC-3F, 850015535$chain:DNA dC->dU-editing enzyme APOBEC-3G, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
apoptosis, caspase activation inhibitor,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
apoptosis, caspase activation inhibitor,UP_SEQ_FEATURE[850010295$chain:Cell death regulator Aven, 850102390$compositionally biased region:Ala/Gly-rich, 850106258$modified residue, 850117295$sequence variant]
aprataxin and PNKP like factor,INTERPRO[450017644$IPR019406:Zinc finger, C2H2, APLF-like]
aprataxin and PNKP like factor,SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790000891$lyase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
aprataxin and PNKP like factor,UP_SEQ_FEATURE[850005876$chain:Aprataxin and PNK-like factor, 850103778$domain:FHA-like, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118875$zinc finger region:PBZ-type 1, 850118876$zinc finger region:PBZ-type 2]
aquaporin 2 (collecting duct),INTERPRO[450000364$IPR000425:Major intrinsic protein, 450010986$IPR012269:Aquaporin]
aquaporin 2 (collecting duct),OMIM_DISEASE[520001468$Diabetes insipidus, nephrogenic, 520001469$Diabetes insipidus, nephrogenic, autosomal recessive]
aquaporin 2 (collecting duct),PIR_SUPERFAMILY[630002399$PIRSF002276:aquaporin]
aquaporin 2 (collecting duct),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000429$diabetes insipidus, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport, 790001637$water channel]
aquaporin 2 (collecting duct),UP_SEQ_FEATURE[850005939$chain:Aquaporin-2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117587$short sequence motif:NPA 1, 850117588$short sequence motif:NPA 2, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ataxin 2,COG_ONTOLOGY[90000102$RNA processing and modification]
ataxin 2,INTERPRO[450008698$IPR009604:LsmAD domain, 450008904$IPR009818:Ataxin-2, C-terminal]
ataxin 2,OMIM_DISEASE[520003637$Newly identified genetic risk variants for celiac disease related to the immune response, 520004634$Spinocerebellar ataxia-2]
ataxin 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001015$neurodegeneration, 790001108$Parkinsonism, 790001162$phosphoprotein, 790001212$polymorphism, 790001431$spinocerebellar ataxia, 790001569$triplet repeat expansion]
ataxin 2,UP_SEQ_FEATURE[850006398$chain:Ataxin-2, 850102570$compositionally biased region:Poly-Gln, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
atrophin 1,INTERPRO[450002600$IPR002951:Atrophin-like, 450016301$IPR017993:Atrophin-1]
atrophin 1,OMIM_DISEASE[520001452$Dentatorubro-pallidoluysian atrophy]
atrophin 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000509$epilepsy, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001569$triplet repeat expansion]
atrophin 1,UP_SEQ_FEATURE[850006808$chain:Atrophin-1, 850102379$compositionally biased region:Ala/Arg-rich, 850102416$compositionally biased region:Arg/Glu-rich (mixed charge), 850102516$compositionally biased region:Glu/Ser-rich, 850102570$compositionally biased region:Poly-Gln, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
breast cancer anti-estrogen resistance 3,INTERPRO[450000852$IPR000980:SH2 motif, 450001677$IPR001895:Guanine-nucleotide dissociation stimulator CDC25, 450018036$IPR019804:Ras guanine-nucleotide exchange factor, conserved site]
breast cancer anti-estrogen resistance 3,SMART[760000129$SM00147:RasGEF, 760000224$SM00252:SH2]
breast cancer anti-estrogen resistance 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain]
breast cancer anti-estrogen resistance 3,UP_SEQ_FEATURE[850008354$chain:Breast cancer anti-estrogen resistance protein 3, 850102568$compositionally biased region:Poly-Asp, 850105149$domain:Ras-GEF, 850105346$domain:SH2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase IV,BBID[10000006$103.Ca2-calmodulin_PK_cascade]
calcium/calmodulin-dependent protein kinase IV,BIOCARTA[30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase IV,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014168$IPR015733:Calcium/calmodulin-dependent protein kinase IV, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase IV,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway]
calcium/calmodulin-dependent protein kinase IV,OMIM_DISEASE[520001930$Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness]
calcium/calmodulin-dependent protein kinase IV,PIR_SUPERFAMILY[630000702$PIRSF000595:calcium/calmodulin-dependent protein kinase, type IV]
calcium/calmodulin-dependent protein kinase IV,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase IV,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000212$calcium binding, 790000217$calmodulin binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase IV,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009094$chain:Calcium/calmodulin-dependent protein kinase type IV, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850110972$region of interest:Autoinhibitory domain, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,INTERPRO[450004794$IPR005331:Carbohydrate sulfotransferase, 8-13, 450016317$IPR018011:Carbohydrate sulfotransferase-related]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,UP_SEQ_FEATURE[850009417$chain:Carbohydrate sulfotransferase 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
casein kinase 1, gamma 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, gamma 1,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, gamma 1,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, gamma 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, gamma 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009782$chain:Casein kinase I isoform gamma-1, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
caspase 8, apoptosis-related cysteine peptidase,BBID[10000037$150.caspase_and_NFKB_activation, 10000063$39.Deg_of_Chromosomal_DNA, 10000065$40.Deg_of_Chrom_DNA_TNF-ind_apoptosis, 10000067$44.Sig_Trans_TNFR1-DR3-DR4_DR5, 10000068$46.P13K_PTEN, 10000093$72.IAP_interaction_with_cell_death_pathways, 10000108$86.Apoptosis_Nematode&_Vert]
caspase 8, apoptosis-related cysteine peptidase,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000060$h_ceramidePathway:Ceramide Signaling Pathway, 30000079$h_d4gdiPathway:D4-GDI Signaling Pathway, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000274$h_soddPathway:SODD/TNFR1 Signaling Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
caspase 8, apoptosis-related cysteine peptidase,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450001895$IPR002138:Peptidase C14, caspase non-catalytic subunit p10, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core, 450014488$IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site]
caspase 8, apoptosis-related cysteine peptidase,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway, 470038843$hsa04210:Apoptosis, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway, 470038864$hsa04622:RIG-I-like receptor signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038923$hsa05416:Viral myocarditis]
caspase 8, apoptosis-related cysteine peptidase,OMIM_DISEASE[520000487$Autoimmune lymphoproliferative syndrome, type IIB, 520000688$Breast cancer, protection against, 520002293$Hepatocellular carcinoma, somatic, 520002967$Lung cancer, protection against]
caspase 8, apoptosis-related cysteine peptidase,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030828$PIRSF500656:caspase-8]
caspase 8, apoptosis-related cysteine peptidase,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
caspase 8, apoptosis-related cysteine peptidase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001509$thiol protease, 790001652$zymogen]
caspase 8, apoptosis-related cysteine peptidase,UP_SEQ_FEATURE[850009845$chain:Caspase-8 subunit p10, 850009847$chain:Caspase-8 subunit p18, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
caspase recruitment domain family, member 8,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450010009$IPR011029:DEATH-like]
caspase recruitment domain family, member 8,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
caspase recruitment domain family, member 8,SMART[760000101$SM00114:CARD]
caspase recruitment domain family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism]
caspase recruitment domain family, member 8,UP_SEQ_FEATURE[850009811$chain:Caspase recruitment domain-containing protein 8, 850103287$domain:CARD, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,BBID[10000004$101.Gprot_coupled_Rec_MAP_Kinase, 10000104$82.TCR_and_Cap_or_SMAC]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000055$h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration, 30000179$h_malPathway:Role of MAL in Rho-Mediated Activation of SRF, 30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway , 30000255$h_rasPathway:Ras Signaling Pathway, 30000265$h_salmonellaPathway:How does salmonella hijack a cell]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis, 470038851$hsa04360:Axon guidance, 470038852$hsa04370:VEGF signaling pathway, 470038853$hsa04510:Focal adhesion, 470038856$hsa04520:Adherens junction, 470038857$hsa04530:Tight junction, 470038869$hsa04660:T cell receptor signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038873$hsa04670:Leukocyte transendothelial migration, 470038877$hsa04722:Neurotrophin signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038883$hsa04912:GnRH signaling pathway, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection, 470038898$hsa05130:Pathogenic Escherichia coli infection, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038902$hsa05212:Pancreatic cancer]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type, 630030779$PIRSF500582:cell division control protein 42]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,SMART[760000148$SM00174:RHO]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000260$cell division, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000952$methylated carboxyl end, 790000953$methylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001235$prenylated cysteine, 790001236$prenylation]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,UP_SEQ_FEATURE[850010330$chain:Cell division control protein 42 homolog, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region, 850118574$splice variant, 850118575$strand, 850118624$turn]
cellular repressor of E1A-stimulated genes 1,INTERPRO[450013146$IPR014631:Cellular repressor of E1A-stimulated genes (CREG)]
cellular repressor of E1A-stimulated genes 1,PIR_SUPERFAMILY[630028383$PIRSF036911:cellular repressor of E1A-stimulated protein, 630028384$PIRSF036911:CREG]
cellular repressor of E1A-stimulated genes 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000635$growth regulation, 790001363$Secreted, 790001405$signal]
cellular repressor of E1A-stimulated genes 1,UP_SEQ_FEATURE[850045457$chain:Protein CREG1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand]
chemokine (C-C motif) ligand 26,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 26,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-C motif) ligand 26,OMIM_DISEASE[520001811$Esophagitis, eosinophilic, susceptibility to, 520001812$Esophagitis, eosinophilic, susceptibility to}. 610247]
chemokine (C-C motif) ligand 26,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types]
chemokine (C-C motif) ligand 26,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 26,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000775$inflammatory response, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 26,UP_SEQ_FEATURE[850008619$chain:C-C motif chemokine 26, 850102883$disulfide bond, 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
chondroitin polymerizing factor,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase]
chondroitin polymerizing factor,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
chondroitin polymerizing factor,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
chondroitin polymerizing factor,UP_SEQ_FEATURE[850011247$chain:Chondroitin sulfate synthase 2, 850102378$compositionally biased region:Ala-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850105986$metal ion-binding site:Divalent metal cation, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,UP_SEQ_FEATURE[850011240$chain:Chondroitin sulfate N- acetylgalactosaminyltransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105986$metal ion-binding site:Divalent metal cation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromosome 1 open reading frame 145,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 1 open reading frame 145,UP_SEQ_FEATURE[850073601$chain:Uncharacterized protein C1orf145, 850118574$splice variant]
chromosome 1 open reading frame 194,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 1 open reading frame 194,UP_SEQ_FEATURE[850073634$chain:Uncharacterized protein C1orf194, 850118574$splice variant]
chromosome 1 open reading frame 91,INTERPRO[450017180$IPR018908:Uncharacterised protein family UPF0546]
chromosome 1 open reading frame 91,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 1 open reading frame 91,UP_SEQ_FEATURE[850097717$chain:UPF0546 membrane protein C1orf91, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
chromosome 10 open reading frame 4,INTERPRO[450017375$IPR019129:Folate-sensitive fragile site protein Fra10Ac1]
chromosome 10 open reading frame 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 10 open reading frame 4,UP_SEQ_FEATURE[850046207$chain:Protein FRA10AC1, 850102554$compositionally biased region:Lys-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 14 open reading frame 119,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 14 open reading frame 119,UP_SEQ_FEATURE[850073158$chain:Uncharacterized protein C14orf119, 850117295$sequence variant]
chromosome 16 open reading frame 53,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 16 open reading frame 53,UP_SEQ_FEATURE[850036954$chain:PAXIP1-associated protein 1, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue]
chromosome 16 open reading frame 93,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
chromosome 16 open reading frame 93,UP_SEQ_FEATURE[850012081$chain:Coiled-coil domain-containing protein C16orf93, 850117294$sequence conflict, 850118574$splice variant]
chromosome 17 open reading frame 45,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 17 open reading frame 45,UP_SEQ_FEATURE[850055486$chain:Putative uncharacterized protein NCRNA00188, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
chromosome 17 open reading frame 49,INTERPRO[450000876$IPR001005:SANT, DNA-binding]
chromosome 17 open reading frame 49,SMART[760000623$SM00717:SANT]
chromosome 17 open reading frame 49,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 17 open reading frame 49,UP_SEQ_FEATURE[850032212$chain:MLL1/MLL complex subunit C17orf49, 850105254$domain:SANT, 850106258$modified residue]
chromosome 18 open reading frame 8,INTERPRO[450008845$IPR009755:Colon cancer-associated Mic1-like]
chromosome 18 open reading frame 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 18 open reading frame 8,UP_SEQ_FEATURE[850073471$chain:Uncharacterized protein C18orf8, 850104777$domain:Mic1, 850106258$modified residue, 850117294$sequence conflict]
chromosome 19 open reading frame 28,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
chromosome 19 open reading frame 28,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
chromosome 19 open reading frame 28,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
chromosome 19 open reading frame 28,UP_SEQ_FEATURE[850070795$chain:Uncharacterized MFS-type transporter C19orf28, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 43,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 19 open reading frame 43,UP_SEQ_FEATURE[850073514$chain:Uncharacterized protein C19orf43, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue]
chromosome 2 open reading frame 66,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
chromosome 2 open reading frame 66,UP_SEQ_FEATURE[850073962$chain:Uncharacterized protein C2orf66, 850117814$signal peptide]
chromosome 20 open reading frame 26,COG_ONTOLOGY[90000064$Energy production and conversion]
chromosome 20 open reading frame 26,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 20 open reading frame 26,UP_SEQ_FEATURE[850073726$chain:Uncharacterized protein C20orf26, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 22 open reading frame 23,INTERPRO[450007262$IPR007914:Uncharacterised protein family UPF0193]
chromosome 22 open reading frame 23,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 22 open reading frame 23,UP_SEQ_FEATURE[850089057$chain:UPF0193 protein EVG1, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 3 open reading frame 44,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 3 open reading frame 44,UP_SEQ_FEATURE[850045939$chain:Protein FAM194A, 850102507$compositionally biased region:Glu-rich, 850117295$sequence variant, 850118574$splice variant]
chromosome 4 open reading frame 49,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 4 open reading frame 49,UP_SEQ_FEATURE[850074203$chain:Uncharacterized protein C4orf49, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 6 open reading frame 47,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 6 open reading frame 47,UP_SEQ_FEATURE[850074374$chain:Uncharacterized protein C6orf47, 850106258$modified residue, 850117295$sequence variant]
chromosome 7 open reading frame 11,OMIM_DISEASE[520004919$Trichothiodystrophy, nonphotosensitive 1]
chromosome 7 open reading frame 11,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 7 open reading frame 11,UP_SEQ_FEATURE[850067052$chain:TTD non-photosensitive 1 protein, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant]
chromosome X open reading frame 15,INTERPRO[450017378$IPR019132:Taxilin]
chromosome X open reading frame 15,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome X open reading frame 15,UP_SEQ_FEATURE[850020586$chain:Gamma-taxilin, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
coenzyme Q2 homolog, prenyltransferase (yeast),INTERPRO[450000460$IPR000537:UbiA prenyltransferase, 450005793$IPR006370:4-hydroxybenzoate polyprenyl transferase]
coenzyme Q2 homolog, prenyltransferase (yeast),KEGG_PATHWAY[470038738$hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis]
coenzyme Q2 homolog, prenyltransferase (yeast),OMIM_DISEASE[520001070$Coenzyme Q10 deficiency]
coenzyme Q2 homolog, prenyltransferase (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000812$Isoprene biosynthesis, 790000919$membrane, 790000969$mitochondrion, 790001547$transferase, 790001550$transit peptide, 790001555$transmembrane, 790001590$ubiquinone biosynthesis]
coenzyme Q2 homolog, prenyltransferase (yeast),UP_SEQ_FEATURE[850036821$chain:Para-hydroxybenzoate-- polyprenyltransferase, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
coiled-coil domain containing 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 62,UP_SEQ_FEATURE[850012031$chain:Coiled-coil domain-containing protein 60, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 91,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
coiled-coil domain containing 91,UP_SEQ_FEATURE[850012074$chain:Coiled-coil domain-containing protein 91, 850111747$region of interest:GGA1-binding motif, 850111906$region of interest:Homodimerization, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
core-binding factor, runt domain, alpha subunit 2; translocated to, 3,INTERPRO[450002557$IPR002893:Zinc finger, MYND-type, 450003419$IPR003894:TAFH/NHR1, 450011925$IPR013289:Eight-Twenty-One, 450011928$IPR013292:Myeloid transforming gene on chromosome 16 (MTG16), 450013345$IPR014896:NHR2-like]
core-binding factor, runt domain, alpha subunit 2; translocated to, 3,PIR_SUPERFAMILY[630016086$PIRSF019480:protein CBFA2T1]
core-binding factor, runt domain, alpha subunit 2; translocated to, 3,SMART[760000489$SM00549:TAFH]
core-binding factor, runt domain, alpha subunit 2; translocated to, 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000434$differentiation, 790000624$golgi apparatus, 790000811$isopeptide bond, 790000919$membrane, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
core-binding factor, runt domain, alpha subunit 2; translocated to, 3,UP_SEQ_FEATURE[850045334$chain:Protein CBFA2T3, 850102586$compositionally biased region:Pro-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105462$domain:TAFH, 850106258$modified residue, 850106259$mutagenesis site, 850113376$region of interest:Mediates interaction with PDE7A (in isoform 2), 850113379$region of interest:Mediates interaction with PRKAR2A, 850113398$region of interest:Mediates localization to the nucleus, 850114445$region of interest:Required for nucleolar targeting (in isoform 1), 850117294$sequence conflict, 850117295$sequence variant, 850117955$site:Breakpoint for translocation to form type-1 RUNX1-CBFA2T3 fusion protein, 850117956$site:Breakpoint for translocation to form type-2 RUNX1-CBFA2T3 fusion protein, 850118574$splice variant, 850118853$zinc finger region:MYND-type]
cytohesin 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor]
cytohesin 1,INTERPRO[450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
cytohesin 1,PIR_SUPERFAMILY[630005444$PIRSF005519:cytohesin]
cytohesin 1,SMART[760000194$SM00222:Sec7, 760000205$SM00233:PH]
cytohesin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor]
cytohesin 1,UP_SEQ_FEATURE[850013985$chain:Cytohesin-1, 850104979$domain:PH, 850105336$domain:SEC7, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
damage-specific DNA binding protein 2, 48kDa,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
damage-specific DNA binding protein 2, 48kDa,KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair, 470038836$hsa04115:p53 signaling pathway, 470038837$hsa04120:Ubiquitin mediated proteolysis]
damage-specific DNA binding protein 2, 48kDa,OMIM_DISEASE[520005124$Xeroderma pigmentosum, group E, DDB-negative subtype]
damage-specific DNA binding protein 2, 48kDa,SMART[760000289$SM00320:WD40]
damage-specific DNA binding protein 2, 48kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001643$xeroderma pigmentosum]
damage-specific DNA binding protein 2, 48kDa,UP_SEQ_FEATURE[850015526$chain:DNA damage-binding protein 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114335$region of interest:Required for interaction with DDB1, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117295$sequence variant, 850117429$short sequence motif:DWD box, 850118574$splice variant, 850118575$strand, 850118624$turn]
death effector domain containing 2,INTERPRO[450001658$IPR001875:Death effector]
death effector domain containing 2,SMART[760000023$SM00031:DED]
death effector domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
death effector domain containing 2,UP_SEQ_FEATURE[850015883$chain:DNA-binding death effector domain- containing protein 2, 850103511$domain:DED, 850117294$sequence conflict, 850117325$short sequence motif:Bipartite nuclear localization signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
decorin,COG_ONTOLOGY[90000070$Function unknown]
decorin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014674$IPR016352:Small leucine-rich proteoglycan, class I, decorin/asporin/byglycan]
decorin,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
decorin,OMIM_DISEASE[520001209$Corneal dystrophy, congenital stromal]
decorin,PIR_SUPERFAMILY[630002608$PIRSF002490:class I small leucine-rich proteoglycan, decorin/asporin/byglycan types, 630002609$PIRSF002490:SLRP_I]
decorin,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
decorin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000308$chondroitin sulfate proteoglycan, 790000346$collagen binding, 790000356$complete proteome, 790000424$dermatan sulfate, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat]
decorin,UP_SEQ_FEATURE[850014440$chain:Decorin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
degenerative spermatocyte homolog 2, lipid desaturase (Drosophila),INTERPRO[450005254$IPR005804:Fatty acid desaturase, type 1, 450010258$IPR011388:Sphingolipid delta4-desaturase, 450012463$IPR013866:Sphingolipid delta4-desaturase, N-terminal]
degenerative spermatocyte homolog 2, lipid desaturase (Drosophila),KEGG_PATHWAY[470038783$hsa00600:Sphingolipid metabolism]
degenerative spermatocyte homolog 2, lipid desaturase (Drosophila),PIR_SUPERFAMILY[630013995$PIRSF017228:Sphnglp_dlt4_des]
degenerative spermatocyte homolog 2, lipid desaturase (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000874$lipid synthesis, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane]
degenerative spermatocyte homolog 2, lipid desaturase (Drosophila),UP_SEQ_FEATURE[850061933$chain:Sphingolipid delta(4)-desaturase/C4- hydroxylase DES2, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850114264$region of interest:Required for C4-hydroxylase activity, 850117295$sequence variant, 850118623$transmembrane region]
dishevelled associated activator of morphogenesis 1,INTERPRO[450002728$IPR003104:Actin-binding FH2 and DRF autoregulatory, 450009531$IPR010472:Diaphanous FH3, 450009532$IPR010473:Diaphanous GTPase-binding, 450013217$IPR014767:Diaphanous autoregulatory, 450013218$IPR014768:GTPase-binding/formin homology 3, 450013867$IPR015425:Actin-binding FH2]
dishevelled associated activator of morphogenesis 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
dishevelled associated activator of morphogenesis 1,SMART[760000441$SM00498:FH2]
dishevelled associated activator of morphogenesis 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm]
dishevelled associated activator of morphogenesis 1,UP_SEQ_FEATURE[850015283$chain:Disheveled-associated activator of morphogenesis 1, 850102586$compositionally biased region:Pro-rich, 850103478$domain:DAD, 850103773$domain:FH1, 850103774$domain:FH2, 850104044$domain:GBD/FH3, 850105852$helix, 850106259$mutagenesis site, 850110834$region of interest:Actin-binding, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
dynactin 2 (p50),INTERPRO[450006392$IPR006996:Dynamitin]
dynactin 2 (p50),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 2 (p50),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000475$dynein, 790000919$membrane, 790000960$microtubule, 790001162$phosphoprotein]
dynactin 2 (p50),UP_SEQ_FEATURE[850016477$chain:Dynactin subunit 2, 850106258$modified residue, 850117294$sequence conflict]
dynein heavy chain domain 1,INTERPRO[450003782$IPR004273:Dynein heavy chain, 450012226$IPR013602:Dynein heavy chain, N-terminal region 2]
dynein heavy chain domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
dynein heavy chain domain 1,UP_SEQ_FEATURE[850016528$chain:Dynein heavy chain domain 1-like protein, 850016529$chain:Dynein heavy chain domain-containing protein 1, 850072967$chain:Uncharacterized protein C11orf47, 850102576$compositionally biased region:Poly-Leu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
echinoderm microtubule associated protein like 2,INTERPRO[450001490$IPR001680:WD40 repeat, 450004577$IPR005108:HELP, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
echinoderm microtubule associated protein like 2,SMART[760000289$SM00320:WD40]
echinoderm microtubule associated protein like 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000960$microtubule, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
echinoderm microtubule associated protein like 2,UP_SEQ_FEATURE[850016885$chain:Echinoderm microtubule-associated protein-like 2, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant]
embryonic ectoderm development,BIOCARTA[30000238$h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails]
embryonic ectoderm development,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
embryonic ectoderm development,SMART[760000289$SM00320:WD40]
embryonic ectoderm development,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001638$wd repeat]
embryonic ectoderm development,UP_SEQ_FEATURE[850039827$chain:Polycomb protein eed, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112312$region of interest:Interaction with EZH2, 850114393$region of interest:Required for interaction with the matrix protein MA of HIV-1, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
ets variant 6,INTERPRO[450000358$IPR000418:Ets, 450002742$IPR003118:Sterile alpha motif/pointed, 450010816$IPR011991:Winged helix repressor DNA-binding, 450012380$IPR013761:Sterile alpha motif-type]
ets variant 6,KEGG_PATHWAY[470038847$hsa04320:Dorso-ventral axis formation]
ets variant 6,OMIM_DISEASE[520002840$Leukemia, acute myeloid, somatic, 520003072$Many sequence variants affecting diversity of adult human height, 520003472$myeloproliverative disorder, chronic, with eosinophilia]
ets variant 6,SMART[760000223$SM00251:SAM_PNT, 760000360$SM00413:ETS]
ets variant 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ets variant 6,UP_SEQ_FEATURE[850065163$chain:Transcription factor ETV6, 850102913$DNA-binding region:ETS, 850105048$domain:PNT, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117872$site:Breakpoint for translocation to form CHIC2-ETV6 in AML, 850117877$site:Breakpoint for translocation to form ETV6-AML1 in ALL, 850117878$site:Breakpoint for translocation to form ETV6-MDS2 in MDS, 850117922$site:Breakpoint for translocation to form PAX5-ETV6, 850118575$strand, 850118624$turn]
eukaryotic translation elongation factor 1 epsilon 1,INTERPRO[450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
eukaryotic translation elongation factor 1 epsilon 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001255$protein biosynthesis]
eukaryotic translation elongation factor 1 epsilon 1,UP_SEQ_FEATURE[850018075$chain:Eukaryotic translation elongation factor 1 epsilon-1, 850104084$domain:GST C-terminal, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
exostoses (multiple) 1,INTERPRO[450003770$IPR004263:Exostosin-like, 450013780$IPR015338:EXTL2, alpha-1,4-N-acetylhexosaminyltransferase]
exostoses (multiple) 1,KEGG_PATHWAY[470038774$hsa00534:Heparan sulfate biosynthesis]
exostoses (multiple) 1,OMIM_DISEASE[520001004$Chondrosarcoma, 520001820$Exostoses, multiple, type 1, 520004915$trichorhinophalangeal syndrome, type II]
exostoses (multiple) 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000673$Hereditary multiple exostoses, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane, 790001580$tumor suppressor]
exostoses (multiple) 1,UP_SEQ_FEATURE[850018286$chain:Exostosin-1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
exportin 7,COG_ONTOLOGY[90000088$Nuclear structure / Intracellular trafficking and secretion]
exportin 7,INTERPRO[450001329$IPR001494:Importin-beta, N-terminal]
exportin 7,PIR_SUPERFAMILY[630009518$PIRSF010822:Exportin]
exportin 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001554$translocation, 790001558$transport]
exportin 7,UP_SEQ_FEATURE[850018365$chain:Exportin-7, 850104418$domain:Importin N-terminal, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 107, member B,INTERPRO[450008633$IPR009533:Protein of unknown function DUF1151]
family with sequence similarity 107, member B,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 107, member B,UP_SEQ_FEATURE[850045822$chain:Protein FAM107B, 850106258$modified residue, 850118574$splice variant]
family with sequence similarity 159, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 159, member A,UP_SEQ_FEATURE[850097651$chain:UPF0514 membrane protein FAM159A, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 167, member B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 167, member B,UP_SEQ_FEATURE[850097362$chain:UPF0484 protein FAM167B]
family with sequence similarity 40, member B,INTERPRO[450011166$IPR012486:N1221-like]
family with sequence similarity 40, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 40, member B,UP_SEQ_FEATURE[850045982$chain:Protein FAM40B, 850102576$compositionally biased region:Poly-Leu, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 53, member C,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
family with sequence similarity 53, member C,UP_SEQ_FEATURE[850046006$chain:Protein FAM53C, 850106258$modified residue, 850117295$sequence variant]
fibronectin type III domain containing 5,INTERPRO[450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
fibronectin type III domain containing 5,SMART[760000051$SM00060:FN3]
fibronectin type III domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001128$peroxisome, 790001405$signal, 790001555$transmembrane]
fibronectin type III domain containing 5,UP_SEQ_FEATURE[850019441$chain:Fibronectin type III domain-containing protein 5, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850117578$short sequence motif:Microbody targeting signal, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
filamin binding LIM protein 1,INTERPRO[450001575$IPR001781:Zinc finger, LIM-type]
filamin binding LIM protein 1,SMART[760000114$SM00132:LIM]
filamin binding LIM protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000263$cell junction, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000864$LIM domain, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
filamin binding LIM protein 1,UP_SEQ_FEATURE[850019487$chain:Filamin-binding LIM protein 1, 850102586$compositionally biased region:Pro-rich, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850104719$domain:LIM zinc-binding 3, 850106259$mutagenesis site, 850111678$region of interest:Filamin-binding, 850114060$region of interest:PLEKHC1-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
glutamate receptor interacting protein 1,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000136$h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology]
glutamate receptor interacting protein 1,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
glutamate receptor interacting protein 1,SMART[760000200$SM00228:PDZ]
glutamate receptor interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001304$repeat, 790001475$synapse]
glutamate receptor interacting protein 1,UP_SEQ_FEATURE[850021576$chain:Glutamate receptor-interacting protein 1, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850104929$domain:PDZ 7, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
glutamate receptor interacting protein 2,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
glutamate receptor interacting protein 2,SMART[760000200$SM00228:PDZ]
glutamate receptor interacting protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001304$repeat]
glutamate receptor interacting protein 2,UP_SEQ_FEATURE[850021577$chain:Glutamate receptor-interacting protein 2, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850104929$domain:PDZ 7, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
growth hormone 2,INTERPRO[450001245$IPR001400:Somatotropin hormone, 450011046$IPR012351:Four-helical cytokine, core, 450016416$IPR018116:Somatotropin hormone, conserved site]
growth hormone 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
growth hormone 2,PIR_SUPERFAMILY[630001964$PIRSF001825:prolactin/lactogen/growth hormone]
growth hormone 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000708$hormone, 790001189$placenta, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth hormone 2,UP_SEQ_FEATURE[850022468$chain:Growth hormone variant, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3,INTERPRO[450000892$IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit, 450001254$IPR001408:G-protein alpha subunit, group I]
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038851$hsa04360:Axon guidance, 470038857$hsa04530:Tight junction, 470038858$hsa04540:Gap junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038878$hsa04730:Long-term depression, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038885$hsa04916:Melanogenesis]
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3,PIR_SUPERFAMILY[630002519$PIRSF002400:GTP-binding regulatory protein Gs alpha chain]
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000028$ADP-ribosylation, 790000189$blocked amino end, 790000356$complete proteome, 790000637$GTP binding, 790000639$gtp-binding, 790000687$heterotrimer, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001100$palmitate, 790001162$phosphoprotein, 790001407$signal transduction, 790001511$thiolester bond, 790001546$transducer]
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3,UP_SEQ_FEATURE[850022731$chain:Guanine nucleotide-binding protein G(k) subunit alpha, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
histone cluster 1, H1e,INTERPRO[450005266$IPR005818:Histone H1/H5, 450005267$IPR005819:Histone H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
histone cluster 1, H1e,PIR_SUPERFAMILY[630029831$PIRSF038219:histone H1]
histone cluster 1, H1e,SMART[760000466$SM00526:H15]
histone cluster 1, H1e,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000950$methylated amino acid, 790000953$methylation, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001432$spleen]
histone cluster 1, H1e,UP_SEQ_FEATURE[850023957$chain:Histone H1.4, 850106258$modified residue, 850111754$region of interest:Globular, 850117295$sequence variant]
histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d,INTERPRO[450000140$IPR000164:Histone H3, 450001877$IPR002119:Histone H2A, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d,PIR_SUPERFAMILY[630002183$PIRSF002048:histone H2A, 630002185$PIRSF002051:histone H3]
histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d,SMART[760000361$SM00414:H2A, 760000374$SM00428:H3]
histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000015$acetyllysine, 790000315$chromosomal protein, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000950$methylated amino acid, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d,UP_SEQ_FEATURE[850023973$chain:Histone H2A type 1-D, 850024087$chain:Histone H3.1, 850024090$chain:Histone H3.2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),INTERPRO[450001972$IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase, 450002724$IPR003100:Argonaute and Dicer protein, PAZ, 450002783$IPR003165:Stem cell self-renewal protein Piwi, 450014426$IPR016040:NAD(P)-binding domain]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038847$hsa04320:Dorso-ventral axis formation]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),OMIM_DISEASE[520000990$Cholestasis, progressive familial intrahepatic 4]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),PIR_SUPERFAMILY[630028161$PIRSF036679:bifunctional 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase, 630029992$PIRSF038460:piwi protein]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000790$intrahepatic cholestasis, 790000915$meiosis, 790000919$membrane, 790000953$methylation, 790001006$nad, 790001077$oogenesis, 790001092$oxidoreductase, 790001212$polymorphism, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001426$spermatogenesis, 790001444$steroidogenesis, 790001551$translation regulation, 790001555$transmembrane]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850001374$chain:3 beta-hydroxysteroid dehydrogenase type 7, 850039216$chain:Piwi-like protein 2, 850104911$domain:PAZ, 850105001$domain:Piwi, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
hydroxysteroid (11-beta) dehydrogenase 1-like,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (11-beta) dehydrogenase 1-like,PIR_SUPERFAMILY[630000148$PIRSF000126:11beta-hydroxysteroid dehydrogenase]
hydroxysteroid (11-beta) dehydrogenase 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001363$Secreted, 790001405$signal]
hydroxysteroid (11-beta) dehydrogenase 1-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850025270$chain:Hydroxysteroid 11-beta-dehydrogenase 1- like protein, 850106307$nucleotide phosphate-binding region:NADP, 850117814$signal peptide, 850118574$splice variant]
hypothetical protein FLJ10404,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
hypothetical protein FLJ10404,UP_SEQ_FEATURE[850075579$chain:Uncharacterized protein KIAA1931, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850117295$sequence variant, 850118574$splice variant]
inactivation escape 2 (non-protein coding); carbonic anhydrase VB, mitochondrial,INTERPRO[450001007$IPR001148:Carbonic anhydrase, alpha-class, catalytic domain, 450016623$IPR018338:Carbonic anhydrase, alpha-class, conserved site, 450016712$IPR018437:Carbonic anhydrase, CA-V, mitochondria]
inactivation escape 2 (non-protein coding); carbonic anhydrase VB, mitochondrial,KEGG_PATHWAY[470038805$hsa00910:Nitrogen metabolism]
inactivation escape 2 (non-protein coding); carbonic anhydrase VB, mitochondrial,PIR_SUPERFAMILY[630001547$PIRSF001392:carbonate dehydratase]
inactivation escape 2 (non-protein coding); carbonic anhydrase VB, mitochondrial,SP_PIR_KEYWORDS[790000356$complete proteome, 790000891$lyase, 790000937$metal-binding, 790000969$mitochondrion, 790001550$transit peptide, 790001648$zinc]
inactivation escape 2 (non-protein coding); carbonic anhydrase VB, mitochondrial,UP_SEQ_FEATURE[850009463$chain:Carbonic anhydrase 5B, mitochondrial, 850106244$metal ion-binding site:Zinc; catalytic, 850118617$transit peptide:Mitochondrion]
insulin-like 6,INTERPRO[450004307$IPR004825:Insulin/IGF/relaxin, 450015420$IPR017100:Insulin-like peptide 6]
insulin-like 6,PIR_SUPERFAMILY[630028563$PIRSF037062:insulin-like peptide 6, 630028564$PIRSF037062:Insulin-like_peptide_6]
insulin-like 6,SMART[760000068$SM00078:IlGF]
insulin-like 6,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
insulin-like 6,UP_SEQ_FEATURE[850026192$chain:Insulin-like peptide INSL6, 850102883$disulfide bond, 850107934$peptide:Insulin-like peptide INSL6 A chain, 850107935$peptide:Insulin-like peptide INSL6 B chain, 850109655$propeptide:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
integral membrane protein 2A,INTERPRO[450006473$IPR007084:BRICHOS]
integral membrane protein 2A,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
integral membrane protein 2A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
integral membrane protein 2A,UP_SEQ_FEATURE[850026207$chain:Integral membrane protein 2A, 850103162$domain:BRICHOS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118623$transmembrane region]
interferon induced transmembrane protein 1 (9-27),INTERPRO[450006944$IPR007593:Interferon-induced transmembrane protein]
interferon induced transmembrane protein 1 (9-27),KEGG_PATHWAY[470038870$hsa04662:B cell receptor signaling pathway]
interferon induced transmembrane protein 1 (9-27),PIR_SUPERFAMILY[630013367$PIRSF016581:interferon-induced transmembrane protein]
interferon induced transmembrane protein 1 (9-27),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
interferon induced transmembrane protein 1 (9-27),UP_SEQ_FEATURE[850026464$chain:Interferon-induced transmembrane protein 1, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
interferon regulatory factor 6,INTERPRO[450001188$IPR001346:Interferon regulatory factor, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016174$IPR017855:SMAD domain-like, 450017709$IPR019471:Interferon regulatory factor-3, 450018048$IPR019817:Interferon regulatory factor, conserved site]
interferon regulatory factor 6,OMIM_DISEASE[520003784$Orofacial cleft 6, 520004058$Popliteal pterygium syndrome, 520005011$van der Woude syndrome]
interferon regulatory factor 6,PIR_SUPERFAMILY[630005637$PIRSF005710:interferon regulatory factor 3-9]
interferon regulatory factor 6,SMART[760000316$SM00348:IRF]
interferon regulatory factor 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
interferon regulatory factor 6,UP_SEQ_FEATURE[850026412$chain:Interferon regulatory factor 6, 850102968$DNA-binding region:Tryptophan pentad repeat, 850117295$sequence variant]
interleukin 1 family, member 9,INTERPRO[450000847$IPR000975:Interleukin-1, 450002876$IPR003297:Interleukin-1 receptor antagonist IL1RA]
interleukin 1 family, member 9,SMART[760000107$SM00125:IL1]
interleukin 1 family, member 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000402$cytokine, 790001212$polymorphism, 790001363$Secreted]
interleukin 1 family, member 9,UP_SEQ_FEATURE[850026496$chain:Interleukin-1 family member 9, 850117295$sequence variant, 850118574$splice variant]
interleukin 32,PIR_SUPERFAMILY[630030007$PIRSF038479:interleukin-32]
interleukin 32,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000402$cytokine, 790001363$Secreted, 790001405$signal]
interleukin 32,UP_SEQ_FEATURE[850026582$chain:Interleukin-32, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae),INTERPRO[450000952$IPR001087:Lipase, GDSL, 450007558$IPR008265:Lipase, GDSL, active site, 450012434$IPR013831:Esterase, SGNH hydrolase-type, subgroup]
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000869$lipid degradation]
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000555$binding site:Substrate, 850000574$binding site:Substrate; via amide nitrogen, 850026837$chain:Isoamyl acetate-hydrolyzing esterase 1 homolog]
junctophilin 2,COG_ONTOLOGY[90000070$Function unknown]
junctophilin 2,INTERPRO[450002977$IPR003409:MORN motif, 450005276$IPR005829:Sugar transporter, conserved site, 450015511$IPR017191:Junctophilin, 450016415$IPR018115:Xylose isomerase, active site]
junctophilin 2,PIR_SUPERFAMILY[630028942$PIRSF037387:Junctophilin]
junctophilin 2,SMART[760000606$SM00698:MORN]
junctophilin 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001356$sarcoplasmic reticulum, 790001555$transmembrane]
junctophilin 2,UP_SEQ_FEATURE[850026986$chain:Junctophilin-2, 850102378$compositionally biased region:Ala-rich, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850116382$repeat:MORN 1, 850116384$repeat:MORN 2, 850116385$repeat:MORN 3, 850116386$repeat:MORN 4, 850116387$repeat:MORN 5, 850116388$repeat:MORN 6, 850116389$repeat:MORN 7, 850116390$repeat:MORN 8, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
karyopherin alpha 7 (importin alpha 8),INTERPRO[450000194$IPR000225:Armadillo, 450002352$IPR002652:Importin-alpha-like, importin-beta-binding region, 450010814$IPR011989:Armadillo-like helical]
karyopherin alpha 7 (importin alpha 8),PIR_SUPERFAMILY[630005601$PIRSF005673:pendulin]
karyopherin alpha 7 (importin alpha 8),SMART[760000159$SM00185:ARM]
karyopherin alpha 7 (importin alpha 8),SP_PIR_KEYWORDS[790000356$complete proteome, 790001266$protein transport, 790001304$repeat, 790001558$transport]
karyopherin alpha 7 (importin alpha 8),UP_SEQ_FEATURE[850025657$chain:Importin subunit alpha-8, 850104197$domain:IBB, 850115674$repeat:ARM 1, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850115690$repeat:ARM 8]
keratin 2,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 2,OMIM_DISEASE[520002579$Ichthyosis bullosa of Siemens]
keratin 2,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000757$Ichthyosis, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 2,UP_SEQ_FEATURE[850027204$chain:Keratin, type II cytoskeletal 2 epidermal, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter]
keratin 80,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 80,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 80,UP_SEQ_FEATURE[850027225$chain:Keratin, type II cytoskeletal 80, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter, 850118574$splice variant]
keratin 81,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 81,OMIM_DISEASE[520003364$Monilethrix]
keratin 81,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 81,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000788$Intermediate filament, 790000821$keratin, 790001212$polymorphism]
keratin 81,UP_SEQ_FEATURE[850027195$chain:Keratin, type II cuticular Hb1, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant]
keratin 82,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 82,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 82,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001212$polymorphism]
keratin 82,UP_SEQ_FEATURE[850027196$chain:Keratin, type II cuticular Hb2, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117295$sequence variant]
kininogen 1,BIOCARTA[30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
kininogen 1,INTERPRO[450000008$IPR000010:Proteinase inhibitor I25, cystatin, 450002128$IPR002395:HMW kininogen, 450016374$IPR018073:Proteinase inhibitor I25, cystatin, conserved site]
kininogen 1,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
kininogen 1,OMIM_DISEASE[520001913$Fitzgerald factor deficiency, 520002334$High molecular weight kininogen deficiency, 520002335$High-molecular-weight kininogen deficiency, 520002744$Kininogen deficiency]
kininogen 1,SMART[760000035$SM00043:CY]
kininogen 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000192$blood coagulation, 790000198$bradykinin, 790000356$complete proteome, 790000398$cysteine proteinase inhibitor, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000745$hydroxylation, 790000747$hydroxyproline, 790000775$inflammatory response, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat, 790001510$thiol protease inhibitor, 790001606$vasoactive, 790001608$vasodilator]
kininogen 1,UP_SEQ_FEATURE[850027560$chain:Kininogen-1, 850027561$chain:Kininogen-1 heavy chain, 850027562$chain:Kininogen-1 light chain, 850102540$compositionally biased region:His-rich, 850102883$disulfide bond, 850103469$domain:Cystatin 1, 850103470$domain:Cystatin 2, 850103471$domain:Cystatin 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850106774$peptide:Bradykinin, 850108110$peptide:Low molecular weight growth-promoting factor, 850108134$peptide:Lysyl-bradykinin, 850109303$peptide:T-kinin, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118073$site:Cleavage; by kallikrein, 850118450$site:Not glycosylated, 850118574$splice variant]
late cornified envelope 1C,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 1C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 1C,UP_SEQ_FEATURE[850028022$chain:Late cornified envelope protein 1C, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
lectin, galactoside-binding, soluble, 13,INTERPRO[450000945$IPR001079:Galectin, carbohydrate recognition domain, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup]
lectin, galactoside-binding, soluble, 13,SMART[760000247$SM00276:GLECT]
lectin, galactoside-binding, soluble, 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000743$hydrolase, 790000848$Lectin, 790000869$lipid degradation, 790001382$serine esterase]
lectin, galactoside-binding, soluble, 13,UP_SEQ_FEATURE[850020422$chain:Galactoside-binding soluble lectin 13, 850104037$domain:Galectin, 850105852$helix, 850118575$strand, 850118624$turn]
leucine rich repeat containing 43,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat]
leucine rich repeat containing 43,UP_SEQ_FEATURE[850028402$chain:Leucine-rich repeat-containing protein 43, 850102507$compositionally biased region:Glu-rich, 850102554$compositionally biased region:Lys-rich, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117295$sequence variant, 850118574$splice variant]
leucine rich repeat neuronal 2,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine rich repeat neuronal 2,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2]
leucine rich repeat neuronal 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine rich repeat neuronal 2,UP_SEQ_FEATURE[850028339$chain:Leucine-rich repeat neuronal protein 2, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
leucine-rich repeats and guanylate kinase domain containing,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450007477$IPR008144:Guanylate kinase, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region]
leucine-rich repeats and guanylate kinase domain containing,SMART[760000063$SM00072:GuKc]
leucine-rich repeats and guanylate kinase domain containing,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001547$transferase]
leucine-rich repeats and guanylate kinase domain containing,UP_SEQ_FEATURE[850028319$chain:Leucine-rich repeat and guanylate kinase domain-containing protein, 850104093$domain:Guanylate kinase-like, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant]
lin-54 homolog (C. elegans),INTERPRO[450004637$IPR005172:Tesmin/TSO1-like, CXC]
lin-54 homolog (C. elegans),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
lin-54 homolog (C. elegans),UP_SEQ_FEATURE[850046710$chain:Protein lin-54 homolog, 850103465$domain:CXC 1, 850103466$domain:CXC 2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
lin-9 homolog (C. elegans),INTERPRO[450009613$IPR010561:DIRP]
lin-9 homolog (C. elegans),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000465$dna synthesis, 790001065$nucleus, 790001162$phosphoprotein, 790001580$tumor suppressor]
lin-9 homolog (C. elegans),UP_SEQ_FEATURE[850046715$chain:Protein lin-9 homolog, 850106258$modified residue, 850114787$region of interest:Sufficient for interaction with RB1, 850117294$sequence conflict, 850118574$splice variant]
lysophosphatidic acid receptor 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
lysophosphatidic acid receptor 5,PIR_SUPERFAMILY[630030133$PIRSF038630:probable G protein-coupled receptor 92, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
lysophosphatidic acid receptor 5,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
lysophosphatidic acid receptor 5,UP_SEQ_FEATURE[850029343$chain:Lysophosphatidic acid receptor 5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
major histocompatibility complex, class I, E,BBID[10000091$70.Signal_peptides_(MHC)_class_I_molecules]
major histocompatibility complex, class I, E,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450010088$IPR011161:MHC class I-like antigen recognition, 450012396$IPR013783:Immunoglobulin-like fold]
major histocompatibility complex, class I, E,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038855$hsa04514:Cell adhesion molecules (CAMs), 470038860$hsa04612:Antigen processing and presentation, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038888$hsa04940:Type I diabetes mellitus, 470038915$hsa05320:Autoimmune thyroid disease, 470038917$hsa05330:Allograft rejection, 470038918$hsa05332:Graft-versus-host disease, 470038923$hsa05416:Viral myocarditis]
major histocompatibility complex, class I, E,OMIM_DISEASE[520000056$A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520003402$Multiple Genetic Loci for Bone Mineral Density and Fractures]
major histocompatibility complex, class I, E,PIR_SUPERFAMILY[630002127$PIRSF001990:class I histocompatibility antigen]
major histocompatibility complex, class I, E,SMART[760000355$SM00407:IGc1]
major histocompatibility complex, class I, E,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000679$heterodimer, 790000763$immune response, 790000919$membrane, 790000955$mhc i, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
major histocompatibility complex, class I, E,UP_SEQ_FEATURE[850024233$chain:HLA class I histocompatibility antigen, alpha chain E, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850110907$region of interest:Alpha-1, 850110908$region of interest:Alpha-2, 850110909$region of interest:Alpha-3, 850111296$region of interest:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A,INTERPRO[450006166$IPR006759:Glycosyl transferase, family 54]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001363$Secreted, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A,UP_SEQ_FEATURE[850004604$chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase A, 850004605$chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase A soluble form, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
mediator complex subunit 20,INTERPRO[450012516$IPR013921:Mediator complex, subunit Med20]
mediator complex subunit 20,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
mediator complex subunit 20,UP_SEQ_FEATURE[850030751$chain:Mediator of RNA polymerase II transcription subunit 20, 850117294$sequence conflict]
mediator complex subunit 26,INTERPRO[450003177$IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type, 450009997$IPR010990:Transcription elongation factor, TFIIS/elongin A/CRSP70, N-terminal, 450013215$IPR014765:Transcription elongation factor, TFIIS/CRSP70, N-terminal, 450016237$IPR017923:TFIIS N-terminal]
mediator complex subunit 26,SMART[760000452$SM00509:TFS2N]
mediator complex subunit 26,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
mediator complex subunit 26,UP_SEQ_FEATURE[850030757$chain:Mediator of RNA polymerase II transcription subunit 26, 850102586$compositionally biased region:Pro-rich, 850105477$domain:TFIIS N-terminal, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
membrane-spanning 4-domains, subfamily A, member 14,INTERPRO[450006606$IPR007237:CD20/IgE Fc receptor beta subunit]
membrane-spanning 4-domains, subfamily A, member 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane]
membrane-spanning 4-domains, subfamily A, member 14,UP_SEQ_FEATURE[850031170$chain:Membrane-spanning 4-domains subfamily A member 14, 850102485$compositionally biased region:Gln-rich, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
metallothionein-like 5, testis-specific (tesmin),INTERPRO[450004637$IPR005172:Tesmin/TSO1-like, CXC]
metallothionein-like 5, testis-specific (tesmin),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001426$spermatogenesis]
metallothionein-like 5, testis-specific (tesmin),UP_SEQ_FEATURE[850063854$chain:Tesmin, 850103465$domain:CXC 1, 850103466$domain:CXC 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria,OMIM_DISEASE[520003266$Methylmalonic aciduria and homocystinuria, cblC type]
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria,SP_PIR_KEYWORDS[790000336$Cobalamin, 790000338$cobalt, 790000356$complete proteome, 790000446$disease mutation, 790001162$phosphoprotein]
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria,UP_SEQ_FEATURE[850031530$chain:Methylmalonic aciduria and homocystinuria type C protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
microtubule-associated protein 4,INTERPRO[450000949$IPR001084:Tubulin-binding Tau protein]
microtubule-associated protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000960$microtubule, 790000961$microtubule binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001484$tandem repeat]
microtubule-associated protein 4,UP_SEQ_FEATURE[850031690$chain:Microtubule-associated protein 4, 850106258$modified residue, 850106259$mutagenesis site, 850109921$region of interest:17 X 14 AA tandem repeats, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115273$repeat:2, 850115405$repeat:26 residues 1, 850115406$repeat:26 residues 2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115585$repeat:8; truncated, 850115588$repeat:9, 850117081$repeat:Tau/MAP 1, 850117082$repeat:Tau/MAP 2, 850117083$repeat:Tau/MAP 3, 850117084$repeat:Tau/MAP 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
mitochondrial ribosomal protein L55,INTERPRO[450016887$IPR018615:Ribosomal protein L55, mitochondrial]
mitochondrial ribosomal protein L55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein L55,UP_SEQ_FEATURE[850001800$chain:39S ribosomal protein L55, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
multiple EGF-like-domains 11,INTERPRO[450000637$IPR000742:EGF-like, type 3, 450001815$IPR002049:EGF-like, laminin, 450005636$IPR006210:EGF-like, 450010351$IPR011489:EMI domain, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular]
multiple EGF-like-domains 11,SMART[760000154$SM00180:EGF_Lam, 760000155$SM00181:EGF]
multiple EGF-like-domains 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
multiple EGF-like-domains 11,UP_SEQ_FEATURE[850032779$chain:Multiple epidermal growth factor-like domains protein 11, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103598$domain:EGF-like 10, 850103601$domain:EGF-like 11, 850103603$domain:EGF-like 12, 850103605$domain:EGF-like 13, 850103607$domain:EGF-like 14, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850103702$domain:EGF-like 9, 850103714$domain:EMI, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
nanos homolog 2 (Drosophila),INTERPRO[450007960$IPR008705:Zinc finger, Nanos]
nanos homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000937$metal-binding, 790001339$rna-binding, 790001426$spermatogenesis, 790001551$translation regulation, 790001648$zinc, 790001651$zinc-finger]
nanos homolog 2 (Drosophila),UP_SEQ_FEATURE[850033725$chain:Nanos homolog 2, 850118855$zinc finger region:Nanos-type]
neuroblastoma breakpoint family, member 4; neuroblastoma breakpoint family, member 6,INTERPRO[450009680$IPR010630:Neuroblastoma breakpoint family]
neuroblastoma breakpoint family, member 4; neuroblastoma breakpoint family, member 6,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001304$repeat]
neuroblastoma breakpoint family, member 4; neuroblastoma breakpoint family, member 6,UP_SEQ_FEATURE[850033946$chain:Neuroblastoma breakpoint family member 4, 850033948$chain:Neuroblastoma breakpoint family member 6, 850102507$compositionally biased region:Glu-rich, 850104832$domain:NBPF 1, 850104834$domain:NBPF 2, 850104835$domain:NBPF 3]
neuroguidin, EIF4E binding protein,INTERPRO[450006519$IPR007146:Sas10/Utp3/C1D]
neuroguidin, EIF4E binding protein,PIR_SUPERFAMILY[630023633$PIRSF031081:PIRSF031081]
neuroguidin, EIF4E binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001551$translation regulation]
neuroguidin, EIF4E binding protein,UP_SEQ_FEATURE[850033995$chain:Neuroguidin, 850106258$modified residue, 850113608$region of interest:Necessary for interaction with EIF4E, 850117295$sequence variant, 850118574$splice variant]
non-SMC element 4 homolog A (S. cerevisiae),INTERPRO[450013303$IPR014854:Nse4]
non-SMC element 4 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
non-SMC element 4 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850034624$chain:Non-structural maintenance of chromosomes element 4 homolog A, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nuclear factor I/X (CCAAT-binding transcription factor),INTERPRO[450000554$IPR000647:CTF transcription factor/nuclear factor 1, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450017785$IPR019548:CTF transcription factor/nuclear factor 1, N-terminal, 450017977$IPR019739:CTF transcription factor/nuclear factor 1, conserved site]
nuclear factor I/X (CCAAT-binding transcription factor),PIR_SUPERFAMILY[630015091$PIRSF018476:nuclear factor 1]
nuclear factor I/X (CCAAT-binding transcription factor),SMART[760000463$SM00523:DWA]
nuclear factor I/X (CCAAT-binding transcription factor),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000460$dna replication, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
nuclear factor I/X (CCAAT-binding transcription factor),UP_SEQ_FEATURE[850034843$chain:Nuclear factor 1 X-type, 850102905$DNA-binding region:CTF/NF-I, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
nucleolar protein 10,INTERPRO[450001490$IPR001680:WD40 repeat, 450011260$IPR012580:NUC153, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site]
nucleolar protein 10,SMART[760000289$SM00320:WD40]
nucleolar protein 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
nucleolar protein 10,UP_SEQ_FEATURE[850035180$chain:Nucleolar protein 10, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nucleolar protein 8,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
nucleolar protein 8,SMART[760000328$SM00360:RRM]
nucleolar protein 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
nucleolar protein 8,UP_SEQ_FEATURE[850035194$chain:Nucleolar protein 8, 850102579$compositionally biased region:Poly-Phe, 850105211$domain:RRM, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nudix (nucleoside diphosphate linked moiety X)-type motif 18,INTERPRO[450000072$IPR000086:NUDIX hydrolase domain, 450000073$IPR000086:NUDIX hydrolase, core]
nudix (nucleoside diphosphate linked moiety X)-type motif 18,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding]
nudix (nucleoside diphosphate linked moiety X)-type motif 18,UP_SEQ_FEATURE[850035296$chain:Nucleoside diphosphate-linked moiety X motif 18, 850104864$domain:Nudix hydrolase, 850105852$helix, 850106148$metal ion-binding site:Magnesium or manganese, 850117294$sequence conflict, 850117628$short sequence motif:Nudix box, 850118574$splice variant, 850118575$strand]
olfactory receptor, family 2, subfamily M, member 4,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily M, member 4,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily M, member 4,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily M, member 4,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily M, member 4,UP_SEQ_FEATURE[850035690$chain:Olfactory receptor 2M4, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 2, subfamily T, member 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily T, member 1,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily T, member 1,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily T, member 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily T, member 1,UP_SEQ_FEATURE[850035694$chain:Olfactory receptor 2T1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 5, subfamily AN, member 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 5, subfamily AN, member 1,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 5, subfamily AN, member 1,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 5, subfamily AN, member 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 5, subfamily AN, member 1,UP_SEQ_FEATURE[850035860$chain:Olfactory receptor 5AN1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),INTERPRO[450000890$IPR001017:Dehydrogenase, E1 component, 450004931$IPR005475:Transketolase, central region, 450010434$IPR011603:2-oxoglutarate dehydrogenase, E1 component]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),KEGG_PATHWAY[470038726$hsa00020:Citrate cycle (TCA cycle), 470038751$hsa00310:Lysine degradation, 470038756$hsa00380:Tryptophan metabolism]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),OMIM_DISEASE[520000227$Alpha-ketoglutarate dehydrogenase deficiency]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),PIR_SUPERFAMILY[630000186$PIRSF000157:2-oxoglutarate dehydrogenase, E1 component, 630000187$PIRSF000157:Oxoglu_dh_E1]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000615$glycolysis, 790000811$isopeptide bond, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001500$thiamin pyrophosphate, 790001503$thiamine pyrophosphate, 790001550$transit peptide, 790001564$tricarboxylic acid cycle, 790001592$ubl conjugation]
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),UP_SEQ_FEATURE[850001162$chain:2-oxoglutarate dehydrogenase, mitochondrial, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
patatin-like phospholipase domain containing 5,INTERPRO[450002343$IPR002641:Patatin]
patatin-like phospholipase domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000869$lipid degradation, 790000873$lipid metabolism, 790001212$polymorphism]
patatin-like phospholipase domain containing 5,UP_SEQ_FEATURE[850036895$chain:Patatin-like phospholipase domain- containing protein 5, 850104907$domain:Patatin, 850117294$sequence conflict, 850117295$sequence variant, 850117474$short sequence motif:GXSXG, 850118574$splice variant]
pecanex-like 2 (Drosophila),INTERPRO[450007089$IPR007735:Pecanex, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
pecanex-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
pecanex-like 2 (Drosophila),UP_SEQ_FEATURE[850037002$chain:Pecanex-like protein 2, 850102597$compositionally biased region:Ser-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
pellino homolog 2 (Drosophila),INTERPRO[450006206$IPR006800:Pellino]
pellino homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
pellino homolog 2 (Drosophila),UP_SEQ_FEATURE[850047205$chain:Protein pellino homolog 2, 850106258$modified residue, 850118575$strand]
peroxisomal biogenesis factor 6,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
peroxisomal biogenesis factor 6,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
peroxisomal biogenesis factor 6,OMIM_DISEASE[520003962$Peroxisomal biogenesis disorder, complementation group 4, 520003963$Peroxisomal biogenesis disorder, complementation group 6]
peroxisomal biogenesis factor 6,SMART[760000335$SM00382:AAA]
peroxisomal biogenesis factor 6,SP_PIR_KEYWORDS[790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001128$peroxisome, 790001129$peroxisome biogenesis, 790001130$peroxisome biogenesis disorder, 790001212$polymorphism, 790001304$repeat, 790001647$zellweger syndrome]
peroxisomal biogenesis factor 6,UP_SEQ_FEATURE[850037992$chain:Peroxisome assembly factor 2, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
phenazine biosynthesis-like protein domain containing,INTERPRO[450003262$IPR003719:Phenazine biosynthesis PhzC/PhzF protein]
phenazine biosynthesis-like protein domain containing,PIR_SUPERFAMILY[630012960$PIRSF016184:PhzC_PhzF]
phenazine biosynthesis-like protein domain containing,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000810$Isomerase, 790001212$polymorphism]
phenazine biosynthesis-like protein domain containing,UP_SEQ_FEATURE[850038162$chain:Phenazine biosynthesis-like domain- containing protein, 850117294$sequence conflict, 850117295$sequence variant]
phosphate regulating endopeptidase homolog, X-linked,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
phosphate regulating endopeptidase homolog, X-linked,INTERPRO[450000617$IPR000718:Peptidase M13, neprilysin, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008005$IPR008753:Peptidase M13, 450014042$IPR015603:Phosphate Regulating Neutral Endopeptidase, 450016770$IPR018497:Peptidase M13, neprilysin, C-terminal]
phosphate regulating endopeptidase homolog, X-linked,OMIM_DISEASE[520002536$Hypophosphatemia, X-linked]
phosphate regulating endopeptidase homolog, X-linked,PIR_SUPERFAMILY[630001335$PIRSF001194:neprilysin-like metallopeptidases]
phosphate regulating endopeptidase homolog, X-linked,SP_PIR_KEYWORDS[790000069$Aminopeptidase, 790000183$biomineralization, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
phosphate regulating endopeptidase homolog, X-linked,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850038367$chain:Phosphate-regulating neutral endopeptidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
phosphoinositide-3-kinase, catalytic, delta polypeptide,INTERPRO[450000293$IPR000341:Phosphoinositide 3-kinase, ras-binding, 450000346$IPR000403:Phosphatidylinositol 3- and 4-kinase, catalytic, 450001114$IPR001263:Phosphoinositide 3-kinase accessory region PIK, 450002150$IPR002420:Phosphoinositide 3-kinase, C2, 450002737$IPR003113:Phosphatidylinositol 3-kinase, p85-binding, 450013875$IPR015433:Phosphatidylinositol Kinase, 450017208$IPR018936:Phosphatidylinositol 3- and 4-kinase, conserved site]
phosphoinositide-3-kinase, catalytic, delta polypeptide,KEGG_PATHWAY[470038776$hsa00562:Inositol phosphate metabolism, 470038828$hsa04012:ErbB signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038832$hsa04070:Phosphatidylinositol signaling system, 470038842$hsa04150:mTOR signaling pathway, 470038843$hsa04210:Apoptosis, 470038852$hsa04370:VEGF signaling pathway, 470038853$hsa04510:Focal adhesion, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038866$hsa04630:Jak-STAT signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway, 470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038873$hsa04670:Leukocyte transendothelial migration, 470038877$hsa04722:Neurotrophin signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038882$hsa04910:Insulin signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038887$hsa04930:Type II diabetes mellitus, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038901$hsa05211:Renal cell carcinoma, 470038902$hsa05212:Pancreatic cancer, 470038903$hsa05213:Endometrial cancer, 470038904$hsa05214:Glioma, 470038905$hsa05215:Prostate cancer, 470038908$hsa05218:Melanoma, 470038910$hsa05220:Chronic myeloid leukemia, 470038911$hsa05221:Acute myeloid leukemia, 470038912$hsa05222:Small cell lung cancer, 470038913$hsa05223:Non-small cell lung cancer]
phosphoinositide-3-kinase, catalytic, delta polypeptide,PIR_SUPERFAMILY[630000693$PIRSF000586:phosphatidylinositol 3-kinase]
phosphoinositide-3-kinase, catalytic, delta polypeptide,SMART[760000124$SM00142:PI3K_C2, 760000125$SM00143:PI3K_p85B, 760000126$SM00144:PI3K_rbd, 760000127$SM00145:PI3Ka, 760000128$SM00146:PI3Kc]
phosphoinositide-3-kinase, catalytic, delta polypeptide,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
phosphoinositide-3-kinase, catalytic, delta polypeptide,UP_SEQ_FEATURE[850038452$chain:Phosphatidylinositol-4,5-bisphosphate 3- kinase catalytic subunit delta isoform, 850104992$domain:PI3K/PI4K, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
pleckstrin homology domain interacting protein,INTERPRO[450001324$IPR001487:Bromodomain, 450001490$IPR001680:WD40 repeat, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450016644$IPR018359:Bromodomain, conserved site, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
pleckstrin homology domain interacting protein,SMART[760000267$SM00297:BROMO, 760000289$SM00320:WD40]
pleckstrin homology domain interacting protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000206$bromodomain, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
pleckstrin homology domain interacting protein,UP_SEQ_FEATURE[850038065$chain:PH-interacting protein, 850102554$compositionally biased region:Lys-rich, 850102572$compositionally biased region:Poly-Glu, 850103167$domain:Bromo 1, 850103168$domain:Bromo 2, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117294$sequence conflict, 850117295$sequence variant]
poly (ADP-ribose) polymerase family, member 8,INTERPRO[450011020$IPR012317:Poly(ADP-ribose) polymerase, catalytic region]
poly (ADP-ribose) polymerase family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000619$glycosyltransferase, 790001006$nad, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
poly (ADP-ribose) polymerase family, member 8,UP_SEQ_FEATURE[850039721$chain:Poly [ADP-ribose] polymerase 8, 850102581$compositionally biased region:Poly-Ser, 850104895$domain:PARP catalytic, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
polymerase (RNA) mitochondrial (DNA directed),INTERPRO[450001854$IPR002092:DNA-directed RNA polymerase, bacteriophage type]
polymerase (RNA) mitochondrial (DNA directed),PIR_SUPERFAMILY[630000858$PIRSF000742:DNA-directed RNA polymerase, 630030651$PIRSF500430:mitochondrial DNA-directed RNA polymerase, metazoan type]
polymerase (RNA) mitochondrial (DNA directed),SP_PIR_KEYWORDS[790000356$complete proteome, 790000468$dna-directed rna polymerase, 790000969$mitochondrion, 790001064$nucleotidyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001547$transferase, 790001550$transit peptide]
polymerase (RNA) mitochondrial (DNA directed),UP_SEQ_FEATURE[850016111$chain:DNA-directed RNA polymerase, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
prefoldin subunit 1,INTERPRO[450002464$IPR002777:Prefoldin beta-like]
prefoldin subunit 1,PIR_SUPERFAMILY[630008914$PIRSF009986:prefoldin subunit 1]
prefoldin subunit 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000288$Chaperone, 790000356$complete proteome, 790001212$polymorphism]
prefoldin subunit 1,UP_SEQ_FEATURE[850040498$chain:Prefoldin subunit 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
pregnancy-zone protein,COG_ONTOLOGY[90000073$General function prediction only]
pregnancy-zone protein,INTERPRO[450001420$IPR001599:Alpha-2-macroglobulin, 450002555$IPR002890:Alpha-2-macroglobulin, N-terminal, 450008198$IPR009048:Alpha-macroglobulin, receptor-binding, 450010454$IPR011625:Alpha-2-macroglobulin, N-terminal 2, 450010455$IPR011626:A-macroglobulin complement component, 450017802$IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming, 450017980$IPR019742:Alpha-2-macroglobulin, conserved site]
pregnancy-zone protein,PIR_SUPERFAMILY[630001802$PIRSF001635:alpha-2-macroglobulin]
pregnancy-zone protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000167$bait region, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001253$protease inhibitor, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal, 790001506$thioester bond]
pregnancy-zone protein,UP_SEQ_FEATURE[850040509$chain:Pregnancy zone protein, 850102729$cross-link:Isoglutamyl cysteine thioester (Cys-Gln), 850105770$glycosylation site:N-linked (GlcNAc...), 850110989$region of interest:Bait region, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
protein kinase, membrane associated tyrosine/threonine 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014559$IPR016235:Membrane-associated tyrosine- and threonine-specific Cdc2-inhibitory kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
protein kinase, membrane associated tyrosine/threonine 1,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038835$hsa04114:Oocyte meiosis, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
protein kinase, membrane associated tyrosine/threonine 1,PIR_SUPERFAMILY[630000675$PIRSF000567:membrane-associated tyrosine- and threonine-specific Cdc2-inhibitory kinase, 630000676$PIRSF000567:TYPK_Myt1]
protein kinase, membrane associated tyrosine/threonine 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
protein kinase, membrane associated tyrosine/threonine 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850031146$chain:Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase, 850102586$compositionally biased region:Pro-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112160$region of interest:Interaction with CDC2-CCNB1, 850112679$region of interest:Interaction with PIN1, 850117294$sequence conflict, 850117295$sequence variant, 850117576$short sequence motif:Membrane-association motif]
protein tyrosine phosphatase, non-receptor type 6,BIOCARTA[30000100$h_epoPathway:EPO Signaling Pathway, 30000125$h_ghPathway:Growth Hormone Signaling Pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000157$h_il3Pathway:IL 3 signaling pathway, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity]
protein tyrosine phosphatase, non-receptor type 6,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450000852$IPR000980:SH2 motif, 450010930$IPR012152:Protein-tyrosine phosphatase, non-receptor type-6, -11, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 6,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway]
protein tyrosine phosphatase, non-receptor type 6,PIR_SUPERFAMILY[630001073$PIRSF000929:non-receptor tyrosine-protein phosphatase, 6/11 types, 630001074$PIRSF000929:Tyr-Ptase_nr_6]
protein tyrosine phosphatase, non-receptor type 6,SMART[760000168$SM00194:PTPc, 760000224$SM00252:SH2]
protein tyrosine phosphatase, non-receptor type 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001397$SH2 domain, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, non-receptor type 6,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067660$chain:Tyrosine-protein phosphatase non-receptor type 6, 850105347$domain:SH2 1, 850105348$domain:SH2 2, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
protocadherin 8,INTERPRO[450001884$IPR002126:Cadherin, 450011801$IPR013164:Cadherin, N-terminal, 450013932$IPR015491:Protocadherin 8]
protocadherin 8,SMART[760000099$SM00112:CA]
protocadherin 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
protocadherin 8,UP_SEQ_FEATURE[850048762$chain:Protocadherin-8, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
reelin,INTERPRO[450000637$IPR000742:EGF-like, type 3, 450002531$IPR002861:Reeler region, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular]
reelin,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
reelin,OMIM_DISEASE[520001996$Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis, 520001999$Genome-Wide Association Identifies a Common Variant in the Reelin Gene That Increases the Risk of Schizophrenia Only in Women, 520002921$Lissencephaly syndrome, Norman-Roberts type]
reelin,SMART[760000155$SM00181:EGF]
reelin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000428$developmental protein, 790000447$disulfide bond, 790000481$egf-like domain, 790000530$extracellular matrix, 790000616$glycoprotein, 790000743$hydrolase, 790000883$lissencephaly, 790000937$metal-binding, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001648$zinc]
reelin,UP_SEQ_FEATURE[850056992$chain:Reelin, 850102405$compositionally biased region:Arg-rich (basic), 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850105168$domain:Reelin, 850105770$glycosylation site:N-linked (GlcNAc...), 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850115719$repeat:BNR 1, 850115720$repeat:BNR 10, 850115721$repeat:BNR 11, 850115722$repeat:BNR 12, 850115723$repeat:BNR 13, 850115724$repeat:BNR 14, 850115725$repeat:BNR 15, 850115726$repeat:BNR 16, 850115727$repeat:BNR 2, 850115728$repeat:BNR 3, 850115729$repeat:BNR 4, 850115730$repeat:BNR 5, 850115731$repeat:BNR 6, 850115732$repeat:BNR 7, 850115733$repeat:BNR 8, 850115734$repeat:BNR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
regulator of G-protein signaling 6,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014319$IPR015898:G-protein, gamma-like subunit]
regulator of G-protein signaling 6,PIR_SUPERFAMILY[630028460$PIRSF036966:regulator of G protein signaling, RGS7 type]
regulator of G-protein signaling 6,SMART[760000041$SM00049:DEP, 760000196$SM00224:GGL, 760000285$SM00315:RGS]
regulator of G-protein signaling 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001408$Signal transduction inhibitor]
regulator of G-protein signaling 6,UP_SEQ_FEATURE[850057035$chain:Regulator of G-protein signaling 6, 850103515$domain:DEP, 850104021$domain:G protein gamma, 850105178$domain:RGS, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118624$turn]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,BIOCARTA[30000208$h_npcPathway:Mechanism of Protein Import into the Nucleus, 30000251$h_ranMSpathway:Role of Ran in mitotic spindle regulation, 30000252$h_ranPathway:Cycling of Ran in nucleocytoplasmic transport]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000449$DNA binding, 790000641$guanine-nucleotide releasing factor, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001484$tandem repeat]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,UP_SEQ_FEATURE[850057014$chain:Regulator of chromosome condensation, 850105852$helix, 850106258$modified residue, 850116898$repeat:RCC1 1, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850116913$repeat:RCC1 6, 850116914$repeat:RCC1 7, 850118575$strand, 850118624$turn]
replication factor C (activator 1) 1, 145kDa,INTERPRO[450001201$IPR001357:BRCT, 450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450010947$IPR012178:DNA replication factor C, large subunit, 450012345$IPR013725:DNA replication factor RFC1, C-terminal]
replication factor C (activator 1) 1, 145kDa,KEGG_PATHWAY[470038817$hsa03030:DNA replication, 470038823$hsa03420:Nucleotide excision repair, 470038824$hsa03430:Mismatch repair]
replication factor C (activator 1) 1, 145kDa,PIR_SUPERFAMILY[630028054$PIRSF036578:DNA replication factor C, large subunit, 630028055$PIRSF036578:RFC1]
replication factor C (activator 1) 1, 145kDa,SMART[760000263$SM00292:BRCT, 760000335$SM00382:AAA]
replication factor C (activator 1) 1, 145kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000460$dna replication, 790000466$dna-binding, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
replication factor C (activator 1) 1, 145kDa,UP_SEQ_FEATURE[850057201$chain:Replication factor C subunit 1, 850103153$domain:BRCT, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
replication protein A4, 34kDa,INTERPRO[450003871$IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type, 450010816$IPR011991:Winged helix repressor DNA-binding, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450013156$IPR014646:Replication protein A, subunit RPA32, 450013341$IPR014892:Replication protein A, C-terminal]
replication protein A4, 34kDa,KEGG_PATHWAY[470038817$hsa03030:DNA replication, 470038823$hsa03420:Nucleotide excision repair, 470038824$hsa03430:Mismatch repair, 470038825$hsa03440:Homologous recombination]
replication protein A4, 34kDa,PIR_SUPERFAMILY[630028436$PIRSF036949:replication protein A, RPA32 subunit, 630028437$PIRSF036949:RPA32]
replication protein A4, 34kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790000460$dna replication, 790001065$nucleus, 790001212$polymorphism]
replication protein A4, 34kDa,UP_SEQ_FEATURE[850057218$chain:Replication protein A 30 kDa subunit, 850117295$sequence variant]
reticulon 4 receptor,COG_ONTOLOGY[90000070$Function unknown]
reticulon 4 receptor,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
reticulon 4 receptor,OMIM_DISEASE[520004400$Schizophrenia, susceptibility to]
reticulon 4 receptor,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
reticulon 4 receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000853$leucine-rich repeat, 790000881$lipoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001405$signal]
reticulon 4 receptor,UP_SEQ_FEATURE[850057339$chain:Reticulon-4 receptor, 850102573$compositionally biased region:Poly-Gly, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850109701$propeptide:Removed in mature form, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117814$signal peptide, 850118575$strand, 850118624$turn]
ribophorin II,INTERPRO[450008060$IPR008814:Ribophorin II]
ribophorin II,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
ribophorin II,PIR_SUPERFAMILY[630015113$PIRSF018501:oligosaccharyltransferase, ribophorin II (Swp1p) subunit]
ribophorin II,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000811$isopeptide bond, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein, 790001592$ubl conjugation]
ribophorin II,UP_SEQ_FEATURE[850016265$chain:Dolichyl-diphosphooligosaccharide-- protein glycosyltransferase subunit 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ribosomal protein L27,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
ribosomal protein L27,INTERPRO[450001002$IPR001141:Ribosomal protein L27e, 450005271$IPR005824:KOW, 450016547$IPR018262:Ribosomal protein L27e, conserved site]
ribosomal protein L27,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L27,PIR_SUPERFAMILY[630002336$PIRSF002205:ribosomal protein L27]
ribosomal protein L27,SMART[760000645$SM00739:KOW]
ribosomal protein L27,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein L27,UP_SEQ_FEATURE[850002698$chain:60S ribosomal protein L27, 850104545$domain:KOW, 850106258$modified residue]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,INTERPRO[450000779$IPR000892:Ribosomal protein S26e]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,PIR_SUPERFAMILY[630002282$PIRSF002153:ribosomal protein S26]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein S26 pseudogene 38; ribosomal protein S26 pseudogene 39; ribosomal protein S26 pseudogene 35; ribosomal protein S26 pseudogene 31; ribosomal protein S26 pseudogene 20; ribosomal protein S26 pseudogene 54; ribosomal protein S26 pseudogene 2; ribosomal protein S26 pseudogene 53; ribosomal protein S26 pseudogene 25; ribosomal protein S26 pseudogene 50; ribosomal protein S26 pseudogene 6; ribosomal protein S26 pseudogene 8; ribosomal protein S26,UP_SEQ_FEATURE[850002020$chain:40S ribosomal protein S26, 850106258$modified residue, 850117294$sequence conflict]
ribosomal protein S27-like,INTERPRO[450000505$IPR000592:Ribosomal protein S27e]
ribosomal protein S27-like,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein S27-like,PIR_SUPERFAMILY[630002283$PIRSF002154:ribosomal protein, S27a/S27e types]
ribosomal protein S27-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001648$zinc, 790001651$zinc-finger]
ribosomal protein S27-like,UP_SEQ_FEATURE[850002033$chain:40S ribosomal protein S27-like protein, 850106258$modified residue, 850117294$sequence conflict, 850118762$zinc finger region:C4-type]
secernin 3,PIR_SUPERFAMILY[630022510$PIRSF029682:PIRSF029682]
secernin 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
secernin 3,UP_SEQ_FEATURE[850059093$chain:Secernin-3, 850117295$sequence variant]
serologically defined colon cancer antigen 8,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
serologically defined colon cancer antigen 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
serologically defined colon cancer antigen 8,UP_SEQ_FEATURE[850060239$chain:Serologically defined colon cancer antigen 8, 850102485$compositionally biased region:Gln-rich, 850114742$region of interest:Sufficient for homodimerization, 850117295$sequence variant, 850118574$splice variant]
signal sequence receptor, beta (translocon-associated protein beta),INTERPRO[450008099$IPR008856:Translocon-associated beta]
signal sequence receptor, beta (translocon-associated protein beta),PIR_SUPERFAMILY[630013173$PIRSF016400:translocon-associated protein, beta subunit, 630013174$PIRSF016400:TRAP_beta]
signal sequence receptor, beta (translocon-associated protein beta),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
signal sequence receptor, beta (translocon-associated protein beta),UP_SEQ_FEATURE[850065890$chain:Translocon-associated protein subunit beta, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
signal transducer and activator of transcription 5B,BBID[10000069$48.mice_minus_JAKs_and_STATs]
signal transducer and activator of transcription 5B,INTERPRO[450000852$IPR000980:SH2 motif, 450001070$IPR001217:STAT transcription factor, core, 450010817$IPR011992:EF-Hand type, 450011041$IPR012345:STAT transcription factor, DNA-binding, subdomain, 450012408$IPR013799:STAT transcription factor, protein interaction, 450012409$IPR013800:STAT transcription factor, all-alpha, 450012410$IPR013801:STAT transcription factor, DNA-binding]
signal transducer and activator of transcription 5B,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038866$hsa04630:Jak-STAT signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038911$hsa05221:Acute myeloid leukemia]
signal transducer and activator of transcription 5B,OMIM_DISEASE[520002199$Growth hormone insensitivity with immunodeficiency, 520002851$Leukemia, acute promyelocytic, STAT5B/RARA type]
signal transducer and activator of transcription 5B,PIR_SUPERFAMILY[630012317$PIRSF015568:signal transducer and transcription activator STAT5A]
signal transducer and activator of transcription 5B,SMART[760000224$SM00252:SH2]
signal transducer and activator of transcription 5B,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain, 790001539$Transcription, 790001543$transcription regulation]
signal transducer and activator of transcription 5B,UP_SEQ_FEATURE[850060807$chain:Signal transducer and activator of transcription 5B, 850105346$domain:SH2, 850106258$modified residue, 850114367$region of interest:Required for interaction with NMI, 850117294$sequence conflict, 850117295$sequence variant]
signal-induced proliferation-associated 1,INTERPRO[450000284$IPR000331:Rap/ran-GAP, 450001316$IPR001478:PDZ/DHR/GLGF]
signal-induced proliferation-associated 1,KEGG_PATHWAY[470038873$hsa04670:Leukocyte transendothelial migration]
signal-induced proliferation-associated 1,OMIM_DISEASE[520003257$Metastasis efficiency, modification of]
signal-induced proliferation-associated 1,SMART[760000200$SM00228:PDZ]
signal-induced proliferation-associated 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
signal-induced proliferation-associated 1,UP_SEQ_FEATURE[850060827$chain:Signal-induced proliferation-associated protein 1, 850104918$domain:PDZ, 850105144$domain:Rap-GAP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
similar to CG10103; KIAA0174,INTERPRO[450004530$IPR005061:Protein of unknown function DUF292, eukaryotic]
similar to CG10103; KIAA0174,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
similar to CG10103; KIAA0174,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001162$phosphoprotein]
similar to CG10103; KIAA0174,UP_SEQ_FEATURE[850026925$chain:IST1 homolog, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112188$region of interest:Interaction with CHMP1A and CHMP1B, 850113022$region of interest:Interaction with VPS37B, 850113026$region of interest:Interaction with VPS4A, VTA1, MITD1 STAMBP and USP8, 850113035$region of interest:Interaction with VTA1, 850117580$short sequence motif:MIT-interacting motif, 850117752$short sequence motif:Type-2 MIT-interacting motif, 850118574$splice variant, 850118624$turn]
similar to THO complex 3; THO complex 3,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
similar to THO complex 3; THO complex 3,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
similar to THO complex 3; THO complex 3,SMART[760000289$SM00320:WD40]
similar to THO complex 3; THO complex 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001304$repeat, 790001339$rna-binding, 790001558$transport, 790001638$wd repeat]
similar to THO complex 3; THO complex 3,UP_SEQ_FEATURE[850064312$chain:THO complex subunit 3, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),SMART[760000193$SM00220:S_TKc]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000988$mrna processing, 790000989$mrna splicing, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001433$Spliceosome, 790001547$transferase]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059960$chain:Serine/threonine-protein kinase PRP4 homolog, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102540$compositionally biased region:His-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
similar to protein phosphatase 1, regulatory subunit 2; protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 4; chromosome 13 open reading frame 18,INTERPRO[450006453$IPR007062:Protein phosphatase inhibitor 2 (IPP-2)]
similar to protein phosphatase 1, regulatory subunit 2; protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 4; chromosome 13 open reading frame 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
similar to protein phosphatase 1, regulatory subunit 2; protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 4; chromosome 13 open reading frame 18,UP_SEQ_FEATURE[850073113$chain:Uncharacterized protein C13orf18, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
sine oculis binding protein homolog (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
sine oculis binding protein homolog (Drosophila),UP_SEQ_FEATURE[850060846$chain:Sine oculis-binding protein homolog, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118808$zinc finger region:FCS-type 1, 850118809$zinc finger region:FCS-type 2]
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear ribonucleoprotein polypeptide E; similar to hCG23490,BIOCARTA[30000273$h_smPathway:Spliceosomal Assembly]
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear ribonucleoprotein polypeptide E; similar to hCG23490,INTERPRO[450001020$IPR001163:Like-Sm ribonucleoprotein, core, 450006064$IPR006649:Like-Sm ribonucleoprotein, eukaryotic and archaea-type, core]
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear ribonucleoprotein polypeptide E; similar to hCG23490,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear ribonucleoprotein polypeptide E; similar to hCG23490,SMART[760000566$SM00651:Sm]
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear ribonucleoprotein polypeptide E; similar to hCG23490,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001433$Spliceosome, 790001478$systemic lupus erythematosus]
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear ribonucleoprotein polypeptide E; similar to hCG23490,UP_SEQ_FEATURE[850061023$chain:Small nuclear ribonucleoprotein E]
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2,UP_SEQ_FEATURE[850032002$chain:Mitochondrial ornithine transporter 2, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,UP_SEQ_FEATURE[850031828$chain:Mitochondrial 2-oxodicarboxylate carrier, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 35, member F2,INTERPRO[450008372$IPR009262:Protein of unknown function DUF914, eukaryotic]
solute carrier family 35, member F2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
solute carrier family 35, member F2,UP_SEQ_FEATURE[850061447$chain:Solute carrier family 35 member F2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
solute carrier family 38, member 2,INTERPRO[450011718$IPR013057:Amino acid transporter, transmembrane]
solute carrier family 38, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000065$amino-acid transport, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001473$Symport, 790001555$transmembrane, 790001558$transport, 790001592$ubl conjugation]
solute carrier family 38, member 2,UP_SEQ_FEATURE[850061211$chain:Sodium-coupled neutral amino acid transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850114199$region of interest:Regulates protein turnover upon amino acid deprivation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 39 (zinc transporter), member 7,INTERPRO[450003234$IPR003689:Zinc/iron permease]
solute carrier family 39 (zinc transporter), member 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000811$isopeptide bond, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport, 790001592$ubl conjugation, 790001648$zinc, 790001650$zinc transport]
solute carrier family 39 (zinc transporter), member 7,UP_SEQ_FEATURE[850102276$chain:Zinc transporter SLC39A7, 850102540$compositionally biased region:His-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 5 (sodium/glucose cotransporter), member 10,INTERPRO[450001537$IPR001734:Sodium/solute symporter, 450016499$IPR018212:Sodium/solute symporter, conserved site, 450018129$IPR019900:Sodium/solute symporter, subgroup]
solute carrier family 5 (sodium/glucose cotransporter), member 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001555$transmembrane, 790001558$transport]
solute carrier family 5 (sodium/glucose cotransporter), member 10,UP_SEQ_FEATURE[850061260$chain:Sodium/glucose cotransporter 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
spermatid associated,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
spermatid associated,UP_SEQ_FEATURE[850061868$chain:Spermatid-associated protein, 850117295$sequence variant, 850118574$splice variant]
spermatogenesis associated 21,INTERPRO[450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
spermatogenesis associated 21,SP_PIR_KEYWORDS[790000211$calcium, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
spermatogenesis associated 21,UP_SEQ_FEATURE[850061886$chain:Spermatogenesis-associated protein 21, 850102586$compositionally biased region:Pro-rich, 850103571$domain:EF-hand, 850117295$sequence variant]
sphingosine-1-phosphate receptor 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450003577$IPR004061:Sphingosine 1-phosphate receptor, 450004844$IPR005386:EDG-8 sphingosine 1-phosphate receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
sphingosine-1-phosphate receptor 5,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
sphingosine-1-phosphate receptor 5,PIR_SUPERFAMILY[630005359$PIRSF005435:LPAR1/S1PR1-like lysophospholipid receptor, 630031145$PIRSF501018:sphingosine 1-phosphate receptor 1-5, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
sphingosine-1-phosphate receptor 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
sphingosine-1-phosphate receptor 5,UP_SEQ_FEATURE[850061968$chain:Sphingosine 1-phosphate receptor 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
splA/ryanodine receptor domain and SOCS box containing 2,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
splA/ryanodine receptor domain and SOCS box containing 2,SMART[760000225$SM00253:SOCS, 760000394$SM00449:SPRY]
splA/ryanodine receptor domain and SOCS box containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001593$ubl conjugation pathway]
splA/ryanodine receptor domain and SOCS box containing 2,UP_SEQ_FEATURE[850062256$chain:SPRY domain-containing SOCS box protein 2, 850103078$domain:B30.2/SPRY, 850105375$domain:SOCS box, 850105852$helix, 850118575$strand, 850118624$turn]
splA/ryanodine receptor domain and SOCS box containing 3,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY]
splA/ryanodine receptor domain and SOCS box containing 3,SMART[760000225$SM00253:SOCS]
splA/ryanodine receptor domain and SOCS box containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001301$receptor]
splA/ryanodine receptor domain and SOCS box containing 3,UP_SEQ_FEATURE[850062257$chain:SPRY domain-containing SOCS box protein 3, 850103078$domain:B30.2/SPRY, 850105375$domain:SOCS box, 850117294$sequence conflict, 850117295$sequence variant]
suppressor of cytokine signaling 2,INTERPRO[450000852$IPR000980:SH2 motif, 450001330$IPR001496:SOCS protein, C-terminal]
suppressor of cytokine signaling 2,KEGG_PATHWAY[470038866$hsa04630:Jak-STAT signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
suppressor of cytokine signaling 2,OMIM_DISEASE[520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520003072$Many sequence variants affecting diversity of adult human height]
suppressor of cytokine signaling 2,PIR_SUPERFAMILY[630006289$PIRSF006354:suppressor of cytokine signaling (SOCS) 1-3]
suppressor of cytokine signaling 2,SMART[760000224$SM00252:SH2, 760000225$SM00253:SOCS]
suppressor of cytokine signaling 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000635$growth regulation, 790001212$polymorphism, 790001397$SH2 domain, 790001408$Signal transduction inhibitor, 790001593$ubl conjugation pathway]
suppressor of cytokine signaling 2,UP_SEQ_FEATURE[850062984$chain:Suppressor of cytokine signaling 2, 850105346$domain:SH2, 850105375$domain:SOCS box, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
suppressor of fused homolog (Drosophila),BIOCARTA[30000269$h_shhPathway:Sonic Hedgehog (Shh) Pathway]
suppressor of fused homolog (Drosophila),INTERPRO[450007120$IPR007768:Suppressor of fused, 450014913$IPR016591:Suppressor of fused protein]
suppressor of fused homolog (Drosophila),KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038907$hsa05217:Basal cell carcinoma]
suppressor of fused homolog (Drosophila),OMIM_DISEASE[520003115$Medulloblastoma, desmoplastic]
suppressor of fused homolog (Drosophila),PIR_SUPERFAMILY[630010097$PIRSF011844:suppressor of fused protein, 630010098$PIRSF011844:Suppressor_of_fused_protein]
suppressor of fused homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001580$tumor suppressor]
suppressor of fused homolog (Drosophila),UP_SEQ_FEATURE[850062990$chain:Suppressor of fused homolog, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
synaptic Ras GTPase activating protein 1 homolog (rat),INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001635$IPR001849:Pleckstrin homology, 450001714$IPR001936:Ras GTPase-activating protein, 450010818$IPR011993:Pleckstrin homology-type]
synaptic Ras GTPase activating protein 1 homolog (rat),OMIM_DISEASE[520003163$Mental retardation, autosomal dominant 5]
synaptic Ras GTPase activating protein 1 homolog (rat),SMART[760000205$SM00233:PH, 760000211$SM00239:C2, 760000292$SM00323:RasGAP]
synaptic Ras GTPase activating protein 1 homolog (rat),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000640$GTPase activation, 790000930$mental retardation, 790001399$sh3-binding]
synaptic Ras GTPase activating protein 1 homolog (rat),UP_SEQ_FEATURE[850056690$chain:Ras GTPase-activating protein SynGAP, 850103199$domain:C2, 850104979$domain:PH, 850105148$domain:Ras-GAP, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
synaptotagmin XI,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001391$IPR001565:Synaptotagmin, 450016334$IPR018029:C2 membrane targeting protein]
synaptotagmin XI,PIR_SUPERFAMILY[630002502$PIRSF002385:B/K protein/synaptotagmin, 630030483$PIRSF500233:synaptotagmin]
synaptotagmin XI,SMART[760000211$SM00239:C2]
synaptotagmin XI,SP_PIR_KEYWORDS[790000211$calcium, 790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001475$synapse, 790001555$transmembrane, 790001592$ubl conjugation]
synaptotagmin XI,UP_SEQ_FEATURE[850063204$chain:Synaptotagmin-11, 850103200$domain:C2 1, 850103201$domain:C2 2, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105925$metal ion-binding site:Calcium 3, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
syntaxin 12,INTERPRO[450000626$IPR000727:Target SNARE coiled-coil region, 450005454$IPR006011:Syntaxin, N-terminal, 450005455$IPR006012:Syntaxin/epimorphin, conserved site]
syntaxin 12,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
syntaxin 12,SMART[760000348$SM00397:t_SNARE, 760000446$SM00503:SynN]
syntaxin 12,SP_PIR_KEYWORDS[790000002$3d-structure, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
syntaxin 12,UP_SEQ_FEATURE[850063261$chain:Syntaxin-12, 850105459$domain:t-SNARE coiled-coil homology, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
syntaxin 18,INTERPRO[450005455$IPR006012:Syntaxin/epimorphin, conserved site, 450017766$IPR019529:SNARE-complex protein Syntaxin-18 N-terminal]
syntaxin 18,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
syntaxin 18,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
syntaxin 18,UP_SEQ_FEATURE[850063270$chain:Syntaxin-18, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
syntaxin 5,INTERPRO[450000626$IPR000727:Target SNARE coiled-coil region, 450005454$IPR006011:Syntaxin, N-terminal, 450005455$IPR006012:Syntaxin/epimorphin, conserved site]
syntaxin 5,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
syntaxin 5,SMART[760000348$SM00397:t_SNARE, 760000446$SM00503:SynN]
syntaxin 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
syntaxin 5,UP_SEQ_FEATURE[850063286$chain:Syntaxin-5, 850105459$domain:t-SNARE coiled-coil homology, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
tau tubulin kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014429$IPR016044:Filament, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016344$IPR018039:Intermediate filament protein, conserved site]
tau tubulin kinase 2,OMIM_DISEASE[520004632$Spinocerebellar ataxia-11]
tau tubulin kinase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000825$kinase, 790001015$neurodegeneration, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001431$spinocerebellar ataxia, 790001547$transferase]
tau tubulin kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850063620$chain:Tau-tubulin kinase 2, 850102582$compositionally biased region:Poly-Thr, 850102597$compositionally biased region:Ser-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
tensin 3,INTERPRO[450000852$IPR000980:SH2 motif, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type, 450012249$IPR013625:Tensin phosphotyrosine-binding domain, 450012613$IPR014019:Phosphatase tensin type, 450012614$IPR014020:Tensin phosphatase, C2 domain]
tensin 3,SMART[760000096$SM00109:C1, 760000224$SM00252:SH2, 760000407$SM00462:PTB]
tensin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain, 790001648$zinc]
tensin 3,UP_SEQ_FEATURE[850063836$chain:Tensin-3, 850102581$compositionally biased region:Poly-Ser, 850103206$domain:C2 tensin-type, 850104989$domain:Phosphatase tensin-type, 850105346$domain:SH2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
tetraspanin 1,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 1,PIR_SUPERFAMILY[630002539$PIRSF002419:CD9 antigen]
tetraspanin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
tetraspanin 1,UP_SEQ_FEATURE[850063970$chain:Tetraspanin-1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tetraspanin 16,BBID[10000086$66.Prot_Interac_w_integrin_domains]
tetraspanin 16,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
tetraspanin 16,UP_SEQ_FEATURE[850063977$chain:Tetraspanin-16, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
thioesterase superfamily member 5,INTERPRO[450006093$IPR006683:Thioesterase superfamily]
thioesterase superfamily member 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790001212$polymorphism]
thioesterase superfamily member 5,UP_SEQ_FEATURE[850064187$chain:Thioesterase superfamily member 5, 850117295$sequence variant]
transgelin 3,COG_ONTOLOGY[90000053$Cytoskeleton]
transgelin 3,INTERPRO[450000477$IPR000557:Calponin repeat, 450000930$IPR001061:Transgelin (SM22-alpha), 450001520$IPR001715:Calponin-like actin-binding, 450002721$IPR003096:SM22/calponin]
transgelin 3,PIR_SUPERFAMILY[630002465$PIRSF002345:smooth muscle protein SM22]
transgelin 3,SMART[760000025$SM00033:CH]
transgelin 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein]
transgelin 3,UP_SEQ_FEATURE[850065772$chain:Transgelin-3, 850103317$domain:CH, 850106258$modified residue, 850115743$repeat:Calponin-like]
transmembrane and ubiquitin-like domain containing 1,INTERPRO[450000534$IPR000626:Ubiquitin, 450018185$IPR019955:Ubiquitin supergroup]
transmembrane and ubiquitin-like domain containing 1,SMART[760000186$SM00213:UBQ]
transmembrane and ubiquitin-like domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001555$transmembrane]
transmembrane and ubiquitin-like domain containing 1,UP_SEQ_FEATURE[850065933$chain:Transmembrane and ubiquitin-like domain- containing protein 1, 850105602$domain:Ubiquitin-like, 850106258$modified residue, 850117605$short sequence motif:Nuclear export signal, 850118623$transmembrane region]
transmembrane protease, serine 13,INTERPRO[450001045$IPR001190:Speract/scavenger receptor, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450015651$IPR017327:Transmembrane serine protease, TMPRSS13, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
transmembrane protease, serine 13,PIR_SUPERFAMILY[630029502$PIRSF037935:TMPRSS13]
transmembrane protease, serine 13,SMART[760000013$SM00020:Tryp_SPc, 760000166$SM00192:LDLa]
transmembrane protease, serine 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001383$Serine protease, 790001409$Signal-anchor, 790001555$transmembrane]
transmembrane protease, serine 13,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850065983$chain:Transmembrane protease, serine 13, 850102378$compositionally biased region:Ala-rich, 850102883$disulfide bond, 850104664$domain:LDL-receptor class A, 850104964$domain:Peptidase S1, 850105384$domain:SRCR, 850105770$glycosylation site:N-linked (GlcNAc...), 850109821$region of interest:12 X 5 AA repeats of A-S-P-A-[GLQR], 850110396$region of interest:4 X 5 AA repeats of T-P-P-G-R, 850115075$repeat:1-1, 850115076$repeat:1-10, 850115078$repeat:1-11, 850115080$repeat:1-12, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850115119$repeat:1-6, 850115122$repeat:1-7, 850115124$repeat:1-8, 850115127$repeat:1-9; approximate, 850115289$repeat:2-1; approximate, 850115291$repeat:2-2, 850115306$repeat:2-3, 850115315$repeat:2-4, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane protein 180,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
transmembrane protein 180,UP_SEQ_FEATURE[850066095$chain:Transmembrane protein 180, 850117294$sequence conflict, 850118623$transmembrane region]
tripartite motif-containing 62,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450005994$IPR006574:SPRY-associated, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 62,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX, 760000524$SM00589:PRY]
tripartite motif-containing 62,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 62,UP_SEQ_FEATURE[850066665$chain:Tripartite motif-containing protein 62, 850103078$domain:B30.2/SPRY, 850117294$sequence conflict, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
tripartite motif-containing 9,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450001654$IPR001870:B302 (SPRY)-like, 450003195$IPR003649:B-box, C-terminal, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450016218$IPR017903:COS domain, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 9,SMART[760000051$SM00060:FN3, 760000158$SM00184:RING, 760000304$SM00336:BBOX, 760000445$SM00502:BBC]
tripartite motif-containing 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 9,UP_SEQ_FEATURE[850066678$chain:Tripartite motif-containing protein 9, 850103078$domain:B30.2/SPRY, 850103408$domain:COS, 850103799$domain:Fibronectin type-III, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118639$zinc finger region:B box-type 1, 850118642$zinc finger region:B box-type 2, 850118911$zinc finger region:RING-type]
two pore segment channel 1,INTERPRO[450005268$IPR005821:Ion transport]
two pore segment channel 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000344$coiled coil, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
two pore segment channel 1,UP_SEQ_FEATURE[850067305$chain:Two pore calcium channel protein 1, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ubiquitin specific peptidase 2,INTERPRO[450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 2,UP_SEQ_FEATURE[850067964$chain:Ubiquitin carboxyl-terminal hydrolase 2, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
ubiquitin specific peptidase 47,INTERPRO[450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 47,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 47,UP_SEQ_FEATURE[850067994$chain:Ubiquitin carboxyl-terminal hydrolase 47, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068083$chain:Ubiquitin-conjugating enzyme E2 D3, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast),INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038892$hsa05012:Parkinson's disease]
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast),SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068088$chain:Ubiquitin-conjugating enzyme E2 G1, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
v-Ha-ras Harvey rat sarcoma viral oncogene homolog,BBID[10000085$65.Integrin_affinity_modulation]
